US3242051A - Coating by phase separation - Google Patents
Coating by phase separation Download PDFInfo
- Publication number
- US3242051A US3242051A US781917A US78191758A US3242051A US 3242051 A US3242051 A US 3242051A US 781917 A US781917 A US 781917A US 78191758 A US78191758 A US 78191758A US 3242051 A US3242051 A US 3242051A
- Authority
- US
- United States
- Prior art keywords
- particles
- solution
- phase
- phase separation
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000005191 phase separation Methods 0.000 title claims description 67
- 238000000576 coating method Methods 0.000 title claims description 53
- 239000011248 coating agent Substances 0.000 title claims description 49
- 239000002245 particle Substances 0.000 claims description 147
- 239000000243 solution Substances 0.000 claims description 95
- 229920000642 polymer Polymers 0.000 claims description 79
- 239000007788 liquid Substances 0.000 claims description 64
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 62
- 238000000034 method Methods 0.000 claims description 57
- 239000012071 phase Substances 0.000 claims description 53
- 239000000084 colloidal system Substances 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 44
- 239000000463 material Substances 0.000 claims description 36
- 229920001577 copolymer Polymers 0.000 claims description 34
- 230000008569 process Effects 0.000 claims description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 23
- 229960005070 ascorbic acid Drugs 0.000 claims description 22
- 235000010323 ascorbic acid Nutrition 0.000 claims description 22
- 239000011668 ascorbic acid Substances 0.000 claims description 22
- 108010010803 Gelatin Proteins 0.000 claims description 20
- 229920000159 gelatin Polymers 0.000 claims description 20
- 239000008273 gelatin Substances 0.000 claims description 20
- 235000019322 gelatine Nutrition 0.000 claims description 20
- 235000011852 gelatine desserts Nutrition 0.000 claims description 20
- 239000007791 liquid phase Substances 0.000 claims description 19
- 239000007787 solid Substances 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 18
- 230000001939 inductive effect Effects 0.000 claims description 15
- 238000005538 encapsulation Methods 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 10
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 10
- 235000011152 sodium sulphate Nutrition 0.000 claims description 10
- 229960000583 acetic acid Drugs 0.000 claims description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 7
- 239000001856 Ethyl cellulose Substances 0.000 claims description 5
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 5
- 229920001249 ethyl cellulose Polymers 0.000 claims description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 claims 2
- 239000000203 mixture Substances 0.000 description 31
- 239000000047 product Substances 0.000 description 22
- -1 e.g. Substances 0.000 description 16
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000012736 aqueous medium Substances 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 12
- 239000000725 suspension Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 9
- PYSRRFNXTXNWCD-UHFFFAOYSA-N 3-(2-phenylethenyl)furan-2,5-dione Chemical compound O=C1OC(=O)C(C=CC=2C=CC=CC=2)=C1 PYSRRFNXTXNWCD-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 8
- 229920000147 Styrene maleic anhydride Polymers 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 238000001879 gelation Methods 0.000 description 7
- 241000220479 Acacia Species 0.000 description 6
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 108010019160 Pancreatin Proteins 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 6
- 229940055695 pancreatin Drugs 0.000 description 6
- 230000035699 permeability Effects 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical class [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 239000010452 phosphate Chemical class 0.000 description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000011790 ferrous sulphate Substances 0.000 description 5
- 235000003891 ferrous sulphate Nutrition 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 5
- RFOHRSIAXQACDB-UHFFFAOYSA-M sodium;2-(2,4-dichlorophenoxy)acetate Chemical compound [Na+].[O-]C(=O)COC1=CC=C(Cl)C=C1Cl RFOHRSIAXQACDB-UHFFFAOYSA-M 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 240000001592 Amaranthus caudatus Species 0.000 description 4
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 235000012735 amaranth Nutrition 0.000 description 4
- 239000004178 amaranth Substances 0.000 description 4
- 239000003125 aqueous solvent Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 239000010413 mother solution Substances 0.000 description 4
- 239000001814 pectin Substances 0.000 description 4
- 229920001277 pectin Polymers 0.000 description 4
- 235000010987 pectin Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 3
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 3
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- 239000001263 FEMA 3042 Substances 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 241000206672 Gelidium Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 description 3
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000002148 esters Chemical group 0.000 description 3
- 239000003337 fertilizer Substances 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- CXYRUNPLKGGUJF-OZVSTBQFSA-M pamine Chemical compound [Br-].C1([C@@H](CO)C(=O)OC2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)C)=CC=CC=C1 CXYRUNPLKGGUJF-OZVSTBQFSA-M 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000003128 rodenticide Substances 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- 150000003440 styrenes Chemical class 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 229920002258 tannic acid Polymers 0.000 description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 3
- 229940033123 tannic acid Drugs 0.000 description 3
- 235000015523 tannic acid Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical class CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- 241000206575 Chondrus crispus Species 0.000 description 2
- 235000009091 Cordyline terminalis Nutrition 0.000 description 2
- 244000289527 Cordyline terminalis Species 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical class C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- MKRNVBXERAPZOP-UHFFFAOYSA-N Starch acetate Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OC(C)=O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 MKRNVBXERAPZOP-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical class [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000008064 anhydrides Chemical group 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001728 carbonyl compounds Chemical class 0.000 description 2
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000002895 emetic Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940015043 glyoxal Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- NGAZZOYFWWSOGK-UHFFFAOYSA-N heptan-3-one Chemical compound CCCCC(=O)CC NGAZZOYFWWSOGK-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000008206 lipophilic material Substances 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- FSQQTNAZHBEJLS-UPHRSURJSA-N maleamic acid Chemical compound NC(=O)\C=C/C(O)=O FSQQTNAZHBEJLS-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 2
- OJUGVDODNPJEEC-UHFFFAOYSA-N phenylglyoxal Chemical compound O=CC(=O)C1=CC=CC=C1 OJUGVDODNPJEEC-UHFFFAOYSA-N 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Chemical class 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 2
- HUEYSSLYFJVUIS-MRFSYGAJSA-N (2s,3r,11bs)-2-[[(1r)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-benzo[a]quinolizine;hydron;chloride Chemical compound Cl.N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC HUEYSSLYFJVUIS-MRFSYGAJSA-N 0.000 description 1
- KRRLUNDQYDGVKX-CJHDCQNGSA-N (Z)-4-amino-4-oxo-2-(2-phenylethenyl)but-2-enoic acid Chemical compound C(=CC1=CC=CC=C1)/C(=C/C(=O)N)/C(=O)O KRRLUNDQYDGVKX-CJHDCQNGSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- 101150034533 ATIC gene Proteins 0.000 description 1
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical class [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- RMBBSOLAGVEUSI-UHFFFAOYSA-H Calcium arsenate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-][As]([O-])([O-])=O.[O-][As]([O-])([O-])=O RMBBSOLAGVEUSI-UHFFFAOYSA-H 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical class [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical class [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- CWVZGJORVTZXFW-UHFFFAOYSA-N [benzyl(dimethyl)silyl]methyl carbamate Chemical compound NC(=O)OC[Si](C)(C)CC1=CC=CC=C1 CWVZGJORVTZXFW-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 229940103357 calcium arsenate Drugs 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-N calcium;phosphoric acid Chemical compound [Ca+2].OP(O)(O)=O.OP(O)(O)=O YYRMJZQKEFZXMX-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 229960001923 emetine hydrochloride Drugs 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940032296 ferric chloride Drugs 0.000 description 1
- WGYSTMQJSAGQIN-UHFFFAOYSA-N formaldehyde;oxaldehyde Chemical compound O=C.O=CC=O WGYSTMQJSAGQIN-UHFFFAOYSA-N 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical class N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960001235 gentian violet Drugs 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Chemical class SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229960000901 mepacrine Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229940053050 neomycin sulfate Drugs 0.000 description 1
- WSGCRAOTEDLMFQ-UHFFFAOYSA-N nonan-5-one Chemical compound CCCCC(=O)CCCC WSGCRAOTEDLMFQ-UHFFFAOYSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- HTSABAUNNZLCMN-UHFFFAOYSA-F paris green Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].[O-][As]=O.[O-][As]=O.[O-][As]=O.[O-][As]=O.[O-][As]=O.[O-][As]=O.CC([O-])=O.CC([O-])=O HTSABAUNNZLCMN-UHFFFAOYSA-F 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- NQQWFVUVBGSGQN-UHFFFAOYSA-N phosphoric acid;piperazine Chemical compound OP(O)(O)=O.C1CNCCN1 NQQWFVUVBGSGQN-UHFFFAOYSA-N 0.000 description 1
- 229960000718 piperazine citrate Drugs 0.000 description 1
- 229960001954 piperazine phosphate Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920002714 polyornithine Polymers 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229940120731 pyruvaldehyde Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- JGFYQVQAXANWJU-UHFFFAOYSA-M sodium fluoroacetate Chemical compound [Na+].[O-]C(=O)CF JGFYQVQAXANWJU-UHFFFAOYSA-M 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000002426 superphosphate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- YTQVHRVITVLIRD-UHFFFAOYSA-L thallium sulfate Chemical compound [Tl+].[Tl+].[O-]S([O-])(=O)=O YTQVHRVITVLIRD-UHFFFAOYSA-L 0.000 description 1
- 229940119523 thallium sulfate Drugs 0.000 description 1
- 229910000374 thallium(I) sulfate Inorganic materials 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 150000004072 triols Chemical class 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
- A01N25/28—Microcapsules or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
- Y10T428/2985—Solid-walled microcapsule from synthetic polymer
- Y10T428/2987—Addition polymer from unsaturated monomers only
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2989—Microcapsule with solid core [includes liposome]
Definitions
- This invention relates to a process for the coating of liquid and solid hydrophilic material and to the products therefrom, and more particularly to the process of precoating said material by phase separation from nonaqueous media prior to coating by phase separation from aqueous media and to the products thereof.
- Coaoervation a particularly useful form of liquid phase separation from aqueous media, is a widely applicable coating procedure capable of providing encapsulated materials having unique characteristics. These unique characteristics include the permissible microscopic size of the capsules, the structure of the coatings, the flexibility in the coating materials used, and the manner in which the coating materials can be modified.
- the present invention comprises the steps of precoating liquid and solid hydrophilic material by the process of phase separation from a non-aqueous medium before encapsulation of said precoated material by the technique of phase separation from aqueous medium.
- the material when coated by the process of the present invention, has a protective coat which comprises two distinct layers, (1) a layer of material (the layer called the precoat) having a lipophilic surface which is deposited by the process of phase separation from non-aqueous medium and (2) a layer of material having a hydrophilic surface deposited by the process of phase separation from aqueous medium.
- the thickness of the coating is there fore the sum of the thickness of the two layers.
- the thickness of the precoat can, within limits, be controlled by the ratio of the amount of material to be coated to the amount of material which separates as a liquid phase.
- the ratio of the amount of material to be coated to the amount of material which separates as a liquid phase.
- more lipophilic material should be used.
- the smaller the particle size of the material to be coated the greater the total surface area to weight, a larger amount of lipophilic material is required to achieve the same layer thickness as that required when employing the same weight of material of larger particle size.
- the thickness of the second layer is variable.
- the process of the present invention is particularly Patented Mar. 22. 1966 advantageous for the coating of solid and liquid matter which is in an extremely fine state of subdivision, i.e., from about 0.5 to 200 microns in diameter; however, the process can also be used for coating of individual particles that are considerably larger, i.c., the particle can be a tablet which is a centimeter or more in diameter, and, obviously, particles of intermediate size can be coated.
- the particular particle size is not critical to the process of the invention, but is determined by the use to which the coated particle is to be employed.
- a micronized powder or finely dispersed liquid (0.5 to 10 micron size) is desirable for vitamins and other food supplements, for substances to be incorporated into cosmetic formulations, and for insecticides;
- a powdered material (up to 200 micron size) is a desirable size for rodenticides.
- Particles when coated by the process of the present invention, have a coating with unique characteristics.
- the coatings surface is hydrophilic in nature and is therefore easily wetted and suspended in water, however the coating is not dissolved by water or the usual organic solvents and is not removed or dispersed by surfactants in an aqueous medium.
- the coating is not melted and the coated particles do not cake together when subjected to warm or humid atmospheric conditions.
- novel encapsulated products of the present invention find applications due to their unique properties in the formulation of compositions for widely diversified fields of use.
- products such as soap bars, lotions, and creams can be formulated containing coated watersoluble ingredients which would be unstable or incompatible in uncoated form in the presence of other ingredients of the particular formulation.
- certain antibacterials such as the chlorinated phenols and neomycin sulfate are incompatible on prolonged contact with soap, the present invention makes possible the formulation of a soap bar containing both of these ingredients.
- coated fertilizers, pesticides, food supplements and medicaments can be advantageously formulated.
- water-soluble fertilizers such as ammonium nitrate, urea and superphosphate can be coated for application to the soil when a slow release or extended action is desirable, e.g., where rapid release would burn the vegetation.
- coated insecticides such as calcium arsenate and copper acetoarsenite can be deposited on vegetation or in the soil without harm to the vegetation; moreover, the insecticide is not dissolved and washed away by moisture or rain, thereby allowing the insecticide to remain where deposited until ingested by the insect.
- Anthelmintic agents such as piperazine phosphate or citrate, and methylrosaniline chloride
- Rodenticides such as calcium cyanide, thallium sulfate and sodium fluoroacetate, which are unstable in the presence of moisture or have an odor or taste repellent to the rodent are advantageously coated.
- a unique application of the coated material is the formulation of rodenticides having in the composition a non-coated, water-soluble antidote or emetic agent; the composition furnishing an auto atic safeguard in case of accidental ingestion by domestic animals -or children. The antidote or emetic can easily be washed away with water by the user or simply be permitted to wash away in actual use by atmospheric moisture or rain.
- Vitamins, minerals, amino acids and other food supplements when coated, can be incorporated in animal feeds and be protected from decomposition during storage periods from such adverse conditions as air, moisture, and incompatible ingredients in the feed composition itself.
- food supplements can be incorporated in compositions for human use.
- the present invention finds application in medicinal treatment of both animals and humans.
- Medicaments can be coated by the methods of the present invention to give a sustained release upon ingestion with resultant sustained therapeutic action. Coatings which will not dissolve in the stomach can be formulated to overcome the problem of gastric irritation or nausea caused by such medicaments as emetine hydrochloride, quinacrine hydrochloride and para-amino-salicylic acid. Similarly, medicaments such as penicillin and certain glandular extracts which are inactivated by the acid condition or enzymes encountered in the stomach are advantageously coated.
- solution means both true solution and colloidal solution.
- phase separation means the separation of a liquid phase from a liquid phase. Phase separation may be thought of as being a precipitation of a liquid precipitate.
- the separating liquid phase is of the same qualitative nature as the original single-phase system, hereinafter called mother phase, from which it separates; it is also qualitatively similar to the remaining liquid, hereinafter called equilibrium liquid with which it is in equilibrium.
- the separating phase differs quantitatively from the mother phase; it is more concentrated in colloid and/or polymer, and less concentrated in solvent.
- coating by phase separation means the phenomenon of inducing phase separation in the presence of suspended particles, the separating phase enveloping or encapsulating the suspended particles to form a mantle around each particle.
- liquid phase-forming macromolecular polymers suitable for use in the precoating step of the present invention can be either synthetic polymers or derivatives of naturally occurring polymers.
- the derivatives of the naturally occurring polymers can be, for example, ethyl cellulose, cellulose acetate, dinitrocellulose, trinitrocellulose, cellulose acetobutyrate, benzyl cellulose, cellulose acetate phthalate, and amylose acetate phthalate.
- Suitable synthetic polymers are macromolecular polymers having an average molecular weight of at least 20,- 000 and having a linear, as opposed to a cross-linked, polymeric structure: for example, those whose polymer units comprise both lipophilic and hydrophilic units, i.e., one class of recurring polymer unit is essentially lipophilic in character (e.g., one derived from styrene, an alkyl ring substituted styrene, an ether or ester substituted ethylene), and the other major recurring unit is essentially hydrophilic in character (e.g., derived from maleic acid, maleic acid amide, acrylic acid, crotonic acid, acrylic acid amide).
- one class of recurring polymer unit is essentially lipophilic in character (e.g., one derived from styrene, an alkyl ring substituted styrene, an ether or ester substituted ethylene), and the other major recurring unit is essentially hydrophilic in character (
- these lipophilic and hydrophilic units preferably comprise a majority of the polymeric units present in the copolymer.
- Other polymer units may also be present in the copolymer, so long as they are present in minor amounts, i.e., less than either the hydrophilic or lipophilic polymer units.
- Included among these copolymers are the hydrolyzed styrene-maleic anhydride copolymers, styrene-maleic acid amide copolymer, the sulfonated polystyrenes, polymethacrylic acid, and methyl vinyl ether-maleic acid copolymer.
- the preferred polymers of this class are the hydrolyzed styrene-maleic anhydride copolymers; the anhydride groups of which are preferably at least hydrolyzed.
- the copolymer can also contain other polymer units in minor amounts, e.g., those derived from acrylonitrile, acrylic acid, methacrylic acid, itaconic acid, vinyl, ethyl vinyl ether, methyl vinyl ether, vinyl chloride, vinylidene chloride, etc., and the like.
- hydrolyzed styrene-maleic anhydride copolyme'r is meant to include these modifications as well as other modifications in the structure and method of preparation which do not alter the essential lipophilic and hydrophilic properties of the copolymer.
- the polymers can be represented by the following formula:
- R represents lipophilic polymer units of which more than are styrene residues, the remainder, when present, being residues of other ethylenic monomers such as those of acrylonitrile, acrylic acid, methacrylic acid, itaconic acid, vinyl chloride, vinylidene chloride, and the like, and R represents hydrophilic polymer units of which more than 50% are maleic acid residues, preferably more than 70%, with the ratio of R to R being from 1:1 to about 4:1, preferably from 1:1 to about 12:1, and n is an integer from about to 1000.
- the average mole'cular weight of the copolymer ranges preferably from about 20,000 to about 200,000.
- Styrene-maleic anhydride copolymer which is readily hydrolyzable to styrene-maleic acid copolymer, is a commercially available modified styrene-maleic anhydride copolymer. This copolymer can be hydrolyzed to obtain a styrene-maleic acid copolymer which is useful in the present invention.
- the hydrolysis can be partial or it can be complete and involves a conversion of the acid anhydride linkages to a-dicarboxylic acid units. It is preferred that the hydrolysis be substantially complete, i.e., more than about 50% complete.
- a styrene-maleic acid copolymer as defined herein is only 0 to 1% ionized and thus is insoluble at this pH, making this copolymer a useful enteric coating for oral pharmaceutical products whose active ingredient is more eflicaciously utilized when absorbed in the intestines rather than the stomach.
- suitable macromolecular polymers are those of the polybasic type (for example, deacetylated chitin, polyvinyl pyridine, styrenevinyl pyridine copolymer, polymeric quaternary ammonium salts), and those of the polyamide type (for eX- ample, polylysine, polyornithine, poly-p-amino-phenylaniline, and polyacrylamide).
- the precoating step of the present invention comprises preparing a mother solution of a liquid phaseforming macromolecular polymer in a non-aqueous liquid; forming a dispersion of liquid or solid hydrophilic material in the mother solution, adding to the thus prepared dispersion a second liquid which is soluble in the first liquid and is a non-solvent to the macromolecular polymer and to the dispersed liquid or solid particles whereby to induce a liquid-liquid phase separation and arated from the liquids, washed, and dried.
- a mother solution of a liquid phaseforming macromolecular polymer in a non-aqueous liquid forming a dispersion of liquid or solid hydrophilic material in the mother solution, adding to the thus prepared dispersion a second liquid which is soluble in the first liquid and is a non-solvent to the macromolecular polymer and to the dispersed liquid or solid particles whereby to induce a liquid-liquid phase separation and arated from the liquids, washed, and dried.
- the precoat can be hardened to impart stability thereto and/ or to reduce permeability.
- the removal of the equilibrium liquid and the separa tion of the precoated particles thereby is preferably car- Mother solution comprising Phase separation inducing additiveSoluble, Nonsolvent Second Liquid 0 Styrene-maleio acid eopolymer.
- phospholipids can also be used to prepare a non-aqueous mother solution capable of producing a liquid-liquid phase separation and encapsulation.
- the lecithins can be dissolved in chloroform and phase separation induced by the addition of ethanol and/ or acetone.
- concentrations of first and second liquids at which the cloudy condition first appears will vary with the concentration of the macromolecular polymer dissolved in the first liquid. Said concentrations can be determined for each particular system independent of the presence of the liquid or solid particle to be coated. When so determined, the appropriate concentrations are thereafter used in the presence of the liquid or solid particles to be coated.
- the temperature considerations involve those temperatures at which a solution of a suitable concentration of the polymer can be obtained in the first liquid, and the boiling points of the first and second liquids.
- the ternperature used for the solution generally, is at least degrees below the boiling point of the lower boiling of the first and second liquids.
- the ratio of macromolecular polymer to the liquid or solid particles to be coated is varied with the thickness of the coating desired.
- the ratio of the polymer to particle can be varied from about 8 parts by weight of polymer to 1 part by weight of particle, to form about 1 part by weight of polymer to about 8 parts by weight of particle.
- the liquid and solid particles for coating by phase separation be insoluble in both the first and second liquids
- the coating of particles with some or appreciable solubility in either the first or second liquids, or in a mixture thereof is not outside the concept of the present invention.
- particles with some solubility in the first liquid can be rendered insoluble, by the addition of the second liquid, prior to the separation of a polymer-rich and a polymer-poor phase.
- the setting of the polymer-rich phase after encapsulation to render the phase immobile can be accomplished in various manners. Illustrative, but not limiting, are lowering the temperature; allowing a spontaneous setting by ageing; adding an acid (i.e., a substance capable of accepting a share in a lone electron pair from a base to form a co-ordinate covalent bond) in the case of a polyacidic polymer; adding a base (i.e., a substance capable of donating a share in a lone electron pair to an acid to form a co-ordinate covalent bond) in the case of a polybasic polymer.
- an acid i.e., a substance capable of accepting a share in a lone electron pair from a base to form a co-ordinate covalent bond
- a base i.e., a substance capable of donating a share in a lone electron pair to an acid to form a co-ordinate covalent bond
- the separation of the precoated particles can be carried out by freeze or spray-drying.
- the drying of the precoated particles can be carried out by simple evaporation, in vacuo, or by the application of heat, depending on the physical characteristics of the non-solvent second liquid.
- the hardening of the precoat can be carried out by utilizing various methods. Illustrative thereof are the addition of dicarbonyl compounds, alum, tannic acid, and ferric chloride; the removal of occluded liquid by drying and/or heating; by changes in pH; and by the use of the Van de Gratf electron accelerator for irradiation.
- the material After having been precoated and separated, the material is then ready to be coated by phase separation from aque ous medium.
- the various ways in which coating by phase separation from aqueous medium can be accomplished are conveniently considered with regard to the composition of the coating material or the composition of the mother phase.
- the mother phase comprises an aqueous solution of a gelable hydrophilic colloid.
- a gelable hydrophilic colloid e.g., gelatin, agaragar, albumin, alginates, casein, pectins, and fibrinogen.
- Such additives include (1) aqueous solutions of electrolytes such as the salts of sodium, potassium, ammonium and lithium cations and sulfate, citrate, acetate and chloride anions or (2) a water-soluble liquid in which the gelable hydrophilic colloid is less soluble than in water such as methanol, ethanol, propanol, acetone and dioxane.
- electrolytes such as the salts of sodium, potassium, ammonium and lithium cations and sulfate, citrate, acetate and chloride anions
- a water-soluble liquid in which the gelable hydrophilic colloid is less soluble than in water such as methanol, ethanol, propanol, acetone and dioxane.
- a critical concentration exists for each additive in each particular colloid system below which phase separation will not be induced. This concentration is easily determined by routine testing as shown in US. Patent 2,800,458.
- the colloid-rich phase on separating collects about the surface of the suspended particle
- the colloid-rich phase separates in the form of microscopic droplets which on the addition of the particle will then collect on the particle and encapsulate it.
- the temperature of the system is lowered below the gelling temperature of the colloid-rich phase thereby changing the colloid mantle from a liquid to a gel.
- the coated particle can then be removed and/or the coating treated to alter its characteristics.
- Another method involves a mother phase comprising an aqueous solution of at least two hydrophilic colloids.
- This method is described in US. Patent 2,800,457 and classified as complex coacervation by H. G. B. Bungenberg de long and Ong Sian Gwan in Biochemische Zeitschrift 221, 182-205 (1930).
- the colloids to be used can be chosen from the various gelable and non-gelable hydrophilic colloids and their derivatives, as, for example, gelatin, agaragar, albumin, alginates, casein, pectins, fibrinogen, starch acetate phthalate, cellulose acetate phthalate, and the like.
- the optimal concentration of the colloids can be determined by routine testing as described in US. Patent 2,800,457. Phase separation is induced by adjustment of pH and/ or addition of water. The proper pH or amount of Water to be added is easily determined by testing as described in the cited patent.
- the coating of the suspended particles then takes place in a similar manner to that described in the first method.
- the gelation step is significant with respect to the permeability of the coating.
- instantaneous gelling of the colloid-rich phase as by adding the liquid colloid-rich phase to ice water, produces a gelled coating having high permeability.
- Prolonged cooling also favors a coating of high permeability.
- the lowest permeability or highest impermeability is obtained with intermediate cooling rates.
- a highly impermeable coating is produced in the case of gelatin on cooling the newly-formed coating from 50 C. to about C. in a period of approximately 30 minutes with continuous stirring.
- the gelled coating is hardened, plasticized or otherwise treated to adapt it to the intended use.
- the colloid-rich phase contains a protein colloid such as gelatin, fibrinogen or collagen
- treating the gelled coating with a 37% aqueous solution of formaldehyde under alkaline conditions produces a hardened shell which can then be dried.
- contact of the coating with the said formaldehyde solution for a period of about 10 mintues is productive of a material having sufiicient hardness and resistance to abrasion to withstand the normal usage of packaging or handling.
- Variations in the hardness of the coating can be obtained by varying the quantity of hardening agent and the period of contact therewith. Hardening likewise has considerable influence on the permeability of the coat, both with respect to the invasion of environmental fluids which would cause disintegration of the coating and to the containment of active ingredients.
- Hardening can be accomplished by a drying process. By removing the water occluded within the mantle, the mantle is hardened.
- the drying can be accomplished by exposure to hot air or other methods such as containment within a closed vessel which contains a desiccant.
- Another method of coating by phase separation employs an aqueous solution of a synthetic linear macromolecular polymer whose polymer units comprise both lipophilic and hydrophilic units.
- a synthetic linear macromolecular polymer whose polymer units comprise both lipophilic and hydrophilic units.
- one class of recurring polymer unit is essentially lipophilic in character, e.g., one derived from styrene, an alkyl ring substituted styrene,
- these lipophilic and hydrophilic units preferably comprise .a majority of the polymeric units present in the polymer. Other polymer units may also be present in the copolymer, so long as they are present in minor amounts, i.e., less than either the hydrophilic or lipophilic polymer units.
- polystyrene-maleic anhydride copolymers include the hydrolyzed styrene-maleic anhydride copolymers, styrene-maleic acid amide polymer, the sulfonated polystyrenes, the carbohydrate acetate phthalates (e.g., starch acetate phthalate. cellulose acetate phthalate and amylose acetate phthalate), polymethacrylic acid, and methyl vinyl ether-maleic acid copolymer.
- carbohydrate acetate phthalates e.g., starch acetate phthalate. cellulose acetate phthalate and amylose acetate phthalate
- polymethacrylic acid e.g., polymethacrylic acid
- methyl vinyl ether-maleic acid copolymer include polymethacrylic acid, and methyl vinyl ether-maleic acid copolymer.
- polymers employed by this method are the hydrolyzed styrene-maleic anhydride copoly- :mers the anhydride groups of which are preferably at least 50% hydrolyzed.
- the copolymer can also contain other polymer units in minor amounts, e.g., those derived from acrylonitrile, acrylic acid, methacrylic acid, itaconic acid, ethyl vinyl ether, methyl vinyl ether, vinyl chloride, vinylidene chloride, etc., and the like.
- solubility of the polymers employed by this method vary considerably in a selected aqueous liquid.
- completely hydrolyzed styrene-maleic anhydride polymer is about 2% soluble in water but at least 20% soluble in a 50:50 mixture of methanol and water.
- solutions of the desired polymer can be prepared in relatively dilute form in water alone.
- concentration of the polymer can be increased by the addition of a solubilizing agent, e.g., another hydrophilic liquid such as, for example, methanol or ethanol.
- a solubilizing agent e.g., another hydrophilic liquid such as, for example, methanol or ethanol.
- Another type of solubilizing agent useful when carboxylic acid polymers are employed are the polysaccharides, e.g.
- galactose polysaccharides e.g., carrageen (derived from Irish moss), available as Sea Kem Type No. 1 from Seaplant Chemical Corporation, New Bedford, Massachusetts.
- solubility of completely hydrolyzed styrene-maleic anhydride copolymer in water can be raised from about 2% to about 7 to 10% in the presence of relatively small amounts of this polysaccharide, e.g., one part to four parts of the copolymer.
- Higher concentrations of the acid polymers can also be achieved by passing a solution of an alkali-metal salt thereof through a bed of sulfonic acid ion exchange resin, e.g., Dowex 50.
- Phase separation is induced by the addition of a solution of a suitable electrolyte as salts of magnesium, ammonia, potassium and lithium cations and sulfate, phosphate, citrate, acetate, chloride, bromide, thiocyanate and nitrate anions.
- a suitable electrolyte as salts of magnesium, ammonia, potassium and lithium cations and sulfate, phosphate, citrate, acetate, chloride, bromide, thiocyanate and nitrate anions.
- the salt should be added in amounts sufiicient to produce a significant pcrcetage thereof by weight per volume of the resulting mixture, e.g., l to 50% and preferably 3 to 20%.
- phase separation is readily determined beforehand by the addition of increasing amounts of the selected additive to a previous solution of the polymer, identical with that to be employed in the encapsulation process, until phase separation occurs in an appreciable amount. This is observable as a visible clouding of the solution.
- the selected polymer is dissolved in the selected aqueous medium, the precoated material is suspended therein, and phase separation is induced by a suitable additive.
- a polymerrich liquid phase separates and encapsulates the suspended particle.
- the pH of the system containing the encapsulated product is adjusted so as to reduce the solubility of the mantle of the thus-produced encapsulated product in the aqueous solvent. If the start ing polymer is acidic in character, then the solution is made acidic. Conversely, if the polymer is basic in character, the solution is made basic. In general, it can be said that in this step, the ionizing properties of the mantle are reduced, thus reducing its afiinity towards the aqueous solvent.
- the correct pH can be determined by visual means, either by observing a change in the appearance of the encapsulated product or by observing the particles under a microscope.
- the mantle or polymer-rich phase as it forms has a somewhat transparent appearance, where as when it is converted to isolatable form by adjustment of the pH, it becomes more opaque or translucent.
- Any strong acid or base can be employed to adjust the pH, e.g., hydrochloric acid, sulfuric acid and sodium or potassium hydroxide.
- the critical step in producing an isolatable product is the step of chilling to below the gelation temperature of the gelable colloid employed.
- gelability is not a critical characteristic of the polymer employed. Instead, the combination of lipophilic and hydrophilic polymer units in the polymer enable the polymer to encapsulate while at the same time having ionizing properties which can be altered by the adjustment of the pH of the aqueous solvent.
- the polymer mantle is formed, it is fixed by adjusting the pH of the aqueous solution in which the encapsulated product is suspended, thereby producing a mantle which is rigid enough to separate the encapsulated product from the suspending liquid.
- the thus-produced encapsulated product can be isolated by centrifugation of filtration to remove the aqueous liquid and then washing the encapsulated material, e.g., with water, but avoiding such vigorous washing as will redissolve a significant amount of the polymer mantle.
- the total reaction product can be freezedried or dried at from about room temperature to about 60 C., e.g., under vacuum
- the mantle of the encapsulated product can be further hardened by exposure to reagents which will chemically alter the surface groups of the polymer mantle, e.g., the polymer can be reacted with a monomer to produce cross'linking or reacted with a salt containing a polyvalent cation, e.g., aluminum sulfate or barium chloride, when the structure of the polymer permits.
- Still another method of coating by phase separation employs an aqueous solution of a styrene-maleic acid copolymer capable of having an electrophoretic charge (of the type described in the preceding method) and a gelable hydrophilic colloid which is of opposite charge at the pH at which significant phase separation takes place.
- a water-soluble hydroxy compound such as a lower alkanol, e.g., methanol and ethanol
- a lower alkylene glycol e.g., ethylene glycol, propylene glycol and trimethylene glycol
- a lower alkyl triol e.g., glycerol
- glycols and triols as defined above are also useful additives to prevent coalescence of the encapsulated product and to produce a product having superior handling properties.
- examples of other anti-coalescing agents are the polyethylene glycols 200 to 600.
- a solution of the selected colloid e.g., gelatin, agar-agar, albumin, alginates, casein, pectins and chitosans.
- a solution of the copolymer and a solution of the colloid are prepared separately.
- a mixture of the colloids, copolymer and the selected aqueous solvent can be heated, e.g., to above the 10 gel temperature of the colloid and the pH adjusted until phase separation occurs.
- the precoated material is suspended in the mother phase and the phase separation induced by adjusting the pH.
- the correct pH for inducing phase separation is readily determined by adding acid or base to a clear solution of a mother phase until clouding occurs, similar to the trial procedures in the previous methods.
- the separating copolymer-colloid-rich phase coatsthe particle, forming a mantle thereover, thus producing the encapsulated product.
- the mantle is ordinarily still quite mobile and not amenable to isolation.
- the mantle is, to a degree, self-hardening and will produce a more stable mantle upon standing, preferably from 30 minutes to several hours or days at a temperature above the gelation temperature of the colloid.
- Techniques well known in the tanning art for the tanning of hides can be employed to accelerate this autohardening, e.g., suspending the encapsulated product for 15 minutes in 10% aqueous ferric chloride or 10% tannic acid in isopropyl alcohol, or in 10% aqueous ferric chloride for 15 minutes at room temperature and then in 20% tannic acid in glycerin.
- hardening agent or agents can be added to the total mixture containing the encapsulated product.
- the encapsulated product can be hardened by exposure to reagents which will chemically alter the surface groups of the polymer mantle, e.g., the poly mer can be reacted with a monomer to produce crosslinking, when the structure of the polymer permits, or irradiated, e.g., with high velocity electron bombardment, e.g., with a Van de Grai'f electro generator, to change the molecular structure of the monomer and, desirably to concomitantly sterilize the encapsulated material.
- reagents which will chemically alter the surface groups of the polymer mantle
- the poly mer can be reacted with a monomer to produce crosslinking, when the structure of the polymer permits, or irradiated, e.g., with high velocity electron bombardment, e.g., with a Van de Grai'f electro generator, to change the molecular structure of the monomer and, desirably to concomitantly steriliz
- the thus-produced encapsulated product can be isolated by centrifugation or filtration to remove the aqueous liquid and then washing the encapsulated material thoroughly, e.g., with water or dilute acid, e.g., dilute acetic acid, and then dried, e.g., freeze or spray dried.
- water or dilute acid e.g., dilute acetic acid
- Example 1 15 milliliters of a 0.5%, w./v., aqueous solution of amaranth is added with vigorous agitation to milliliters of a 5.0%, w./v., solution of cellulose acetate butyrate in methylethyl ketone. This mixture is then passed through a hand homogenizer three times. Enough additional butyrate solution is added through the homogenizer to make 150 ml. of emulsion.
- the emulsion is then heated to 55 C. on a steam bath while being stirred rapidly. An additional 15 m1. of amaranth solution is added at this time.
- a solution of 50 gm. of gelatin in 450 ml. of water is prepared at from about 40 to 50 C.
- the precoated amaranth solution is added to this system, with adequate stirring to maintain the particles uniformly suspended.
- ethanol 95%) is slowly added to the system.
- the concentration of ethanol reaches about 50% v./v.
- the gelatin-rich phase separates and encapsulates the suspended particles.
- the whole mixture is cooled to from about 2 to 6 C. to gel the gelatin coating.
- the coated material is separated from the bulk of the residual liquid, advantageously by centrifuging. Thereafter the coated amaranth solution is washed thoroughly by suspending in 2000 ml. of water and then removed by centrifuge and dried.
- Example 2 A solution of 10 gm. of benzyl cellulose is prepared at about 40 C. in 300 ml. of trichloroethylene. About gm. of finely divided sodium(2,4-dichlorophenoxy)acetate is suspended in the system with adequate stirring. With stirring and with the temperature maintained at about 40 C., propanol is added. When the concentration of propanol reaches about 51% v./v., a benzyl-cellulose-rich phase separation occurs and the sodium(2,4-dichlorophenoxy)acetate particles are coated by the separating phase. The whole mixture is cooled to room temperature. Thereafter, the precoated material is separated, by centrifuging, thoroughly washed with propanol, and allowed to dry.
- a solution of 100 gm. of gelatin in 900 ml. of water is prepared at from about 40 to 50 C.
- the precoated sodium(2,4-dichlorophenoxy) acetate is added to this system, with adequate stirring to maintain the particles uniformly suspended.
- ethanol is slowly added to the system.
- the concentration of ethanol reaches about 50% v./v.
- the gelatin-rich phase separates and encapsulates the suspended particles.
- the whole mixture is cooled to from about 2 to 6 C. to gel the gelatin coating.
- the coated material is separated from the bulk of the residual liquid, advantageously by centrifuging. Thereafter the coated sodium(2,4-dichlorophenoxy)acetate is washed thoroughly by suspending in 2000 ml. of water and then removed by centrifuge and dried.
- the coated sodium(2,4-dichlorophenoxy)acetate in the form of a dry powder can be placed in commerce for later suspension in water to be usefully applied as a slow release weed control.
- Example 3 A solution of 50 gm. of cellulose acetobutyrate is prepared in 1000 ml. of methyl ethyl ketone at about 55 C. About 12.5 gm. of powdered dibasic calcium phosphate is dispersed in the solution with adequate stirring to maintain the phosphate particles uniformly suspended. With stirring and with the temperature maintained at about 50 C., isopropyl ether is added. When the concentration of the ether reaches about 42% v./v., a polymer-rich phase separates and coats the phosphate particles. The system is cooled to room temperature. Thereafter, the precoated phosphate particles are separated, advantageously by centrifuging, washed with isopropyl ether and allowed to dry.
- a solution of 50 gm. of pork skin gelatin in 450 ml. of water is prepared at from about 40 to 50 C.
- the precoated phosphate particles are added to the system, with adequate stirring to maintain the particles uniform- 1y suspended.
- ethanol 97% is slowly added to the system.
- concentration of ethanol reaches about 50% v./v.
- phase separation is induced and the separating colloid-rich phase encapsulates the dispersed precoated phosphate particles.
- the whole mixture is cooled to below 10 C. to gel the colloid-rich phase.
- the coated dibasic calcium phosphate is separated from the bulk of the residual liquid, advantageously by centrifuging. Thereafter the coated material is washed thoroughly by suspending in 2000 ml. of water and then removed by centrifuge and dried.
- coated particles of dibasic calcium phosphate are usefully applied to the soil for use as a slow release fertilizer.
- Example 4 About 20 gm. of ethyl cellulose are dissolved in a mixture of 400 ml. of xylene and 80 ml. of ethanol. About 5 gm. of microcrystalline ascorbic acid are suspended in the solution and 500 ml. of Skellysolve B (ii-hexane) is added dropwise whereby phase separation is induced. The system is spray dried and the precoated ascorbic acid particles collected.
- Skellysolve B ii-hexane
- styrene-maleic acid copolymer Twenty-five grams of styrene-maleic acid copolymer are dissolved in about 1250 ml. of water and heated to 80 C. The precoated ascorbic acid particles are suspended in the solution. With constant stirring of the suspension, 275 ml. of a 20% sodium sulfate solution, heated to 80 C. are added dropwise (upon addition of the sodium sulfate solution; phase separation is induced and encapsulation of the particles takes place). The suspension is maintained at 80 C. for 20 minutes.
- the coated ascorbic acid particles are removed by cen trifugation and washed several times by alternatively suspending in Water and separating by centrifugation. As a final step the particles are suspended in 500 ml. of water and freeze dried.
- the coated particles of ascorbic acid are usefully administered to animals (including humans) as a therapeutic or prophylactic treatment.
- the particles can be suspended in aqueous solutions of the Water-soluble vitamins, including cyanocobalamin, the protective coating preventing the degradation of cyanocobalarnin by ascorbic acid.
- Example 5 A solution is prepared with 10 gm. of styrene-maleic acid copolymer and ml. of ethanol. About 80 gm. of powdered pancreatin are dispersed in the solution. With continuous stirring, ethylbutyl ketone is added to the suspension until a concentration of about 60% v./v. is attained. As a result of the addition of ketone, phase separation and encapsulation of the suspended pancreatin occurs. The precoated pancreatin is recovered, Washed with butylethyl ketone and dried.
- acacia powder Twenty-seven grams of acacia powder are dissolved in 167 ml. of water heated to 40 C. When the acacia has dissolved, a sufficient amount of a 20% acetic acid solution is added to give a pH of 3.9. The temperature of the solution is maintained at 40 C.
- the precoated particles of pancreatin are dispersed in the acacia solution and the gelatin solution is slowly added with stirring.
- About 415 ml. of water, previously heated to 40 C. is added dropwise to bring about separation of the colloid-rich phase which encapsulates the suspended pancreatin particles.
- the mixture is maintained at 40 C. for about 20 minutes and then cooled over a period of about 30 minutes to about 4 C.
- the mixture is maintained below 6 C. for one hour.
- the pH of the mixture is adjusted to 9.5 by the addition of 10% sodium hy- 13 droxide solution and about 20 ml. of a 30% glyoxal solution is added dropwise.
- the solution is maintained below 6 C. for an additional one hour and then allowed to warm to room temperature.
- the coated particles are removed by centrifugation.
- the particles are twice washed by dispersing in 1000 ml. of water and Separated by centrifugation. The particles are then redispersed in 1000 ml. of water and spray dried.
- the coated pancreatin is thus protected after oral ingestion from the destructive action of the acidic stomach juices.
- Example 6 About 40 gm. of micronized methylscopolamine hydrobromide are suspended in 500 ml. of a w./v. solution of cellulose acetate butyrate in methylethyl ketone. The suspension is heated to- 55 C. and 350 ml. of isopropyl ether added dropwise to the system with continuous stirring. The system is cooled slowly to room temperature and the precoated methylscopolamine hydrobromide par- 'ticles separated by centrifugation, Washed with isopropyl ether and dried in vacuo.
- styrene-maleic acid copolymer and about 5 gm. of Sea Kern, Type No. 1 are mixed and-dis- 'persed in 100 ml. of propylene glycol.
- About 500 ml. of water are added to the dispersion and heated to 80 C. to dissolve.
- the precoated methylscopolamine hydrobromide particles are suspended in the solution and a solution of about 20 gm. of gelation dissolved in 100 ml. of water at 800 C. is added dropwise.
- the suspension is maintained at 80 C. with stirring for minutes and then cooled to 4 C. over a period of 30 minutes.
- the suspension is maintained at 4 C. for one hour and then about ml.
- aqueous formaldehyde solution 37% aqueous formaldehyde solution is added and the pH adjusted to pH 8.0 with a su'fiicient amount of 10% aqueous sodium hydroxide solution.
- the suspension is maintained at 4 C. for one hour and then the encapsulated urea removed by centrifugation.
- the encapsulated particles are resuspended in 1% hydrochloric acid solution and spray dried.
- Example 7 Seventy-five grams of micronized ferrous sulfate, exsiccated, U.S.P. is suspended with constant agitation to 1250 ml. of a 20% (w./v.) solution of lecithin (centrolex H) in chloroform and heated to 50 C. Fifteen hundred milliliters of a 50:50 (v./v.) solution of ethanol and acetone is added slowly and with stirring to the suspension (upon the addition of the ethanol-acetone solution phase separation occurs and encapsulation of the ferrous sulfate particles takes place). The system is cooled to at least 20 C. and filtered.
- the precoated ferrous sulfate particles are removed from the filter and dispersed in 1000 cc. of acetone at room temperature.
- the surface of the lecithin precoat is treated by the addition of 1000 cc. of a saturated solution of aluminum chloride in 95% ethanol.
- the suspension is stirred for minutes and the precoated ferrous sulfate removed by filtration and air dried.
- acacia powder Twenty-seven grams of acacia powder are dissolved in 167 ml. of water heated to C. When the acacia has dissolved, a sufficient amount of a 20% acetic acid solution is added to give a pH of 3.9. The temperature of the solution is maintained at 40 C.
- the precoated ferrous sulfate is dispersed in the acacia solution and the gelatin solution is slowly added with stirring. About 415 ml. of water, previously heated to 40 C. is added dropwise to bring about separation of the colloid-rich phase which coats the wax-coated methionine. The mixture is maintained at 40 C. for
- the particles are washed twice by dispersing in 1000 ml. of water and separated by centrifugation. The particles are then redispersed in 1000 ml. of water and spray dried.
- a process for the coating en masse of a plurality of individual discrete fluid and solid particles of hydrophilic matter which comprises: (1) preparing a solution of a liquid phase forming macromolecular polymer in a first nonaqueous liquid; (2) dispersing in said solution a plurality of individual discrete particles selected from the group consisting of insoluble fluid hydrophilic particles and insoluble solid hydrophilic particles; (3) adding a second liquid, solublein the first liquid and non-solvent for said macromolecular polymer and said dispersed particles, whereby phase separation is induced and the separating phase precoats each of the dispersed particles; (4) setting the polymer-rich precoat; (5) separating said precoated particles; (6) suspending the precoated particles in an aqueous solution of a gelable hydrophilic colloid; (7) inducing phase separation, whereby to cause the formation of a colloid-rich phase and the encapsulation of each of the suspended precoated particles, the foregoing steps (6) and (7) being carried out at
- a process for the coating en masse of a plurality of individual discrete fluid and solid particles of hydrophilic matter which comprises: (1) preparing a solution of a liquid phase forming macromolecular polymer in a first non-aqueous liquid; (2) dispersing in said solution a plurality of individual discrete particles selected from the group consisting of insoluble fluid hydrophilic particles and insoluble solid hydrophilic particles; (3) adding a second liquid, soluble in the first liquid and non-solvent for said macromolecular polymer and said dispersed particles, whereby phase separation is induced and the separating phase precoats each of the dispersed particles; (4) setting the polymer-rich precoat; (5) separating said precoated particles; (6) suspending the precoated particles in an aqueous solution of at least twocolloids, at least one of which is gellable and one of which has the opposite electrophoretic charge from the remaining colloids; (7) inducing phase separation, whereby to cause the formation of a colloid-rich phase and the encapsulation
- a process for the coating en masse of a plurality of individual discrete fluid and solid particles of hydrophilic matter which comprises: (1) preparing a solution of a liquid phase forming macromolecular polymer in a first non-aqueous liquid; (2) dispersing in said solution a plurality of individual discrete particles selected from the group consisting of insoluble fluid hydrophilic particles and insoluble solid hydrophilic particles; (3) adding a second liquid, soluble in the first liquid and nonsolvent for said macromolecular polymer and said dispersed particles, whereby phase separation is induced and the separating phase precoats each of the dispersed particles; (4) setting the polymer-rich precoat; (5) separating said precoated particles; (6) suspending the precoated particles in an aqueous solution of a linear macromolecular synthetic polymer,- a majority of whose polymer units comprise both lipophilic and hydrophilic units; (7) inducing phase separation, whereby to cause the formation of a polymer-rich phase and the encapsulation of each
- a process for the coating en masse of a plurality of individual discrete fluid and solid particles of hydrophilic matter which comprises: (1) preparing a solution of a liquid phase forming macromolecular polymer in a first non-aqueous liquid; (2) dispersing in said solution a plurality of individual discrete particles selected from the group consisting of insoluble fluid hydrophilic particles and insoluble solid hydrophilic particles; (3) adding a second liquid, soluble in the first liquid and nonsolvent for said macromolecular polymer and said dispersed particles, whereby phase separation is induced and the separating phase precoats each of the dispersed particles; (4) setting the polymer-rich precoat; (5) separating said precoated particles; (6) suspending the precoated particles in an aqueous solution of an electrophoretically chargeable styrene-maleic acid copolymer and an oppositely electrophoretically chargeable gellable colloid at a pH outside the range which induces liquid phase separation; (7) inducing phase separation by the adjustment
- a process for coating en masse individual discrete particles of water soluble solid material which comprises: (1) preparing a solution of ethylcellulose in a solvent system comprising a major portion of Xylene and a minor portion of ethanol;
- phase separation by means of the addition of n-hexane to the said solution whereby phase separation is induced and the separating phase envelopes individually and precoats individually each of the suspended discrete particles of water soluble solid material;
- phase separation inducing phase separation by means of the dropwi e addit on of an q eous sodium sulfate solution heated to about C. whereby phase separation is induced and the separating phase envelopes individually and coats individually each of the suspended precoated particles;
- a process for coating en masse individual discrete particles of microcrystalline ascorbic acid which comprises:
- phase separation by means of the addition of n-hexane to the said solution whereby phase separation is induced and the separating phase envelopes individually and precoats individually each of the suspended discrete particles of ascorbic acid;
- phase separation inducing phase separation by means of the dropwise addition of an aqueous sodium sulfate solution heated to about 80 C. whereby phase separation is induced and the separating phase envelopes individually and coats individually each of the suspended precoated particles of ascorbic acid;
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Description
United States Patent 3,242,051 COATING BY PHASE SEPARATION Everett N. Hiestand, Portage Township, Kalamazoo County, John G. Wagner, Kalamazoo, and Edwin L.
Knoeche], Kalamazoo Township, Kalamazoo County,
Mich., assignors, by mesne assignments, to The National Cash Register Company, Dayton, Ohio, a corporation of Maryland No Drawing. Filed Dec. 22, 1958, Ser. No. 781,917
Claims. (Cl. 167-81) This invention relates to a process for the coating of liquid and solid hydrophilic material and to the products therefrom, and more particularly to the process of precoating said material by phase separation from nonaqueous media prior to coating by phase separation from aqueous media and to the products thereof.
Coaoervation, a particularly useful form of liquid phase separation from aqueous media, is a widely applicable coating procedure capable of providing encapsulated materials having unique characteristics. These unique characteristics include the permissible microscopic size of the capsules, the structure of the coatings, the flexibility in the coating materials used, and the manner in which the coating materials can be modified.
Coating by phase separation from aqueous media, prior to the present invention, was not a satisfactory method for coating either water-soluble material or Water-insoluble material of a hydrophilic nature. Obviously, watersoluble material will dissolve in the aqueous media from which the liquid phase separates. Although some of the dissolved molecular units will be encapsulated, this will not occur in sufficient quantity to be practical. Probably due to the hydrophilic surface, water-insoluble hydrophilic material will not be encapsulated by the separating phase.
The present invention comprises the steps of precoating liquid and solid hydrophilic material by the process of phase separation from a non-aqueous medium before encapsulation of said precoated material by the technique of phase separation from aqueous medium.
The material, when coated by the process of the present invention, has a protective coat which comprises two distinct layers, (1) a layer of material (the layer called the precoat) having a lipophilic surface which is deposited by the process of phase separation from non-aqueous medium and (2) a layer of material having a hydrophilic surface deposited by the process of phase separation from aqueous medium. The thickness of the coating is there fore the sum of the thickness of the two layers.
In general, the thickness of the precoat can, within limits, be controlled by the ratio of the amount of material to be coated to the amount of material which separates as a liquid phase. Thus, if a thicker lipophilic layer is desired, more lipophilic material should be used. As is apparent, the smaller the particle size of the material to be coated, the greater the total surface area to weight, a larger amount of lipophilic material is required to achieve the same layer thickness as that required when employing the same weight of material of larger particle size.
Similarly, the thickness of the second layer is variable.
The process of the present invention is particularly Patented Mar. 22. 1966 advantageous for the coating of solid and liquid matter which is in an extremely fine state of subdivision, i.e., from about 0.5 to 200 microns in diameter; however, the process can also be used for coating of individual particles that are considerably larger, i.c., the particle can be a tablet which is a centimeter or more in diameter, and, obviously, particles of intermediate size can be coated. The particular particle size is not critical to the process of the invention, but is determined by the use to which the coated particle is to be employed. For example, a micronized powder or finely dispersed liquid (0.5 to 10 micron size) is desirable for vitamins and other food supplements, for substances to be incorporated into cosmetic formulations, and for insecticides; a powdered material (up to 200 micron size) is a desirable size for rodenticides.
Particles, when coated by the process of the present invention, have a coating with unique characteristics. The coatings surface is hydrophilic in nature and is therefore easily wetted and suspended in water, however the coating is not dissolved by water or the usual organic solvents and is not removed or dispersed by surfactants in an aqueous medium. The coating is not melted and the coated particles do not cake together when subjected to warm or humid atmospheric conditions.
The novel encapsulated products of the present invention find applications due to their unique properties in the formulation of compositions for widely diversified fields of use.
In the cosmetic field, products such as soap bars, lotions, and creams can be formulated containing coated watersoluble ingredients which would be unstable or incompatible in uncoated form in the presence of other ingredients of the particular formulation. For example, since certain antibacterials such as the chlorinated phenols and neomycin sulfate are incompatible on prolonged contact with soap, the present invention makes possible the formulation of a soap bar containing both of these ingredients.
In the agricultural field, coated fertilizers, pesticides, food supplements and medicaments can be advantageously formulated. For example, water-soluble fertilizers such as ammonium nitrate, urea and superphosphate can be coated for application to the soil when a slow release or extended action is desirable, e.g., where rapid release would burn the vegetation. For the control of pests, coated insecticides such as calcium arsenate and copper acetoarsenite can be deposited on vegetation or in the soil without harm to the vegetation; moreover, the insecticide is not dissolved and washed away by moisture or rain, thereby allowing the insecticide to remain where deposited until ingested by the insect. Anthelmintic agents, such as piperazine phosphate or citrate, and methylrosaniline chloride, when coated can be incorporated into feed material for domestic animals, the coated anthelmintic thereby being tasteless in the feed and also protected from decomposition during storage of the feed. Rodenticides such as calcium cyanide, thallium sulfate and sodium fluoroacetate, which are unstable in the presence of moisture or have an odor or taste repellent to the rodent are advantageously coated. A unique application of the coated material is the formulation of rodenticides having in the composition a non-coated, water-soluble antidote or emetic agent; the composition furnishing an auto atic safeguard in case of accidental ingestion by domestic animals -or children. The antidote or emetic can easily be washed away with water by the user or simply be permitted to wash away in actual use by atmospheric moisture or rain.
Vitamins, minerals, amino acids and other food supplements, when coated, can be incorporated in animal feeds and be protected from decomposition during storage periods from such adverse conditions as air, moisture, and incompatible ingredients in the feed composition itself. In a similar manner food supplements can be incorporated in compositions for human use.
The present invention finds application in medicinal treatment of both animals and humans. Medicaments can be coated by the methods of the present invention to give a sustained release upon ingestion with resultant sustained therapeutic action. Coatings which will not dissolve in the stomach can be formulated to overcome the problem of gastric irritation or nausea caused by such medicaments as emetine hydrochloride, quinacrine hydrochloride and para-amino-salicylic acid. Similarly, medicaments such as penicillin and certain glandular extracts which are inactivated by the acid condition or enzymes encountered in the stomach are advantageously coated.
As used in the present specification the term solution means both true solution and colloidal solution.
The term phase separation means the separation of a liquid phase from a liquid phase. Phase separation may be thought of as being a precipitation of a liquid precipitate. The separating liquid phase is of the same qualitative nature as the original single-phase system, hereinafter called mother phase, from which it separates; it is also qualitatively similar to the remaining liquid, hereinafter called equilibrium liquid with which it is in equilibrium. The separating phase differs quantitatively from the mother phase; it is more concentrated in colloid and/or polymer, and less concentrated in solvent.
As used in the present specification the term coating by phase separation means the phenomenon of inducing phase separation in the presence of suspended particles, the separating phase enveloping or encapsulating the suspended particles to form a mantle around each particle.
The liquid phase-forming macromolecular polymers suitable for use in the precoating step of the present invention can be either synthetic polymers or derivatives of naturally occurring polymers.
The derivatives of the naturally occurring polymers can be, for example, ethyl cellulose, cellulose acetate, dinitrocellulose, trinitrocellulose, cellulose acetobutyrate, benzyl cellulose, cellulose acetate phthalate, and amylose acetate phthalate.
Suitable synthetic polymers are macromolecular polymers having an average molecular weight of at least 20,- 000 and having a linear, as opposed to a cross-linked, polymeric structure: for example, those whose polymer units comprise both lipophilic and hydrophilic units, i.e., one class of recurring polymer unit is essentially lipophilic in character (e.g., one derived from styrene, an alkyl ring substituted styrene, an ether or ester substituted ethylene), and the other major recurring unit is essentially hydrophilic in character (e.g., derived from maleic acid, maleic acid amide, acrylic acid, crotonic acid, acrylic acid amide). In combination, these lipophilic and hydrophilic units preferably comprise a majority of the polymeric units present in the copolymer. Other polymer units may also be present in the copolymer, so long as they are present in minor amounts, i.e., less than either the hydrophilic or lipophilic polymer units. Included among these copolymers are the hydrolyzed styrene-maleic anhydride copolymers, styrene-maleic acid amide copolymer, the sulfonated polystyrenes, polymethacrylic acid, and methyl vinyl ether-maleic acid copolymer.
Among the preferred polymers of this class are the hydrolyzed styrene-maleic anhydride copolymers; the anhydride groups of which are preferably at least hydrolyzed. The copolymer can also contain other polymer units in minor amounts, e.g., those derived from acrylonitrile, acrylic acid, methacrylic acid, itaconic acid, vinyl, ethyl vinyl ether, methyl vinyl ether, vinyl chloride, vinylidene chloride, etc., and the like. As used in the present specification, the term hydrolyzed styrene-maleic anhydride copolyme'r is meant to include these modifications as well as other modifications in the structure and method of preparation which do not alter the essential lipophilic and hydrophilic properties of the copolymer.
The polymers can be represented by the following formula:
wherein R represents lipophilic polymer units of which more than are styrene residues, the remainder, when present, being residues of other ethylenic monomers such as those of acrylonitrile, acrylic acid, methacrylic acid, itaconic acid, vinyl chloride, vinylidene chloride, and the like, and R represents hydrophilic polymer units of which more than 50% are maleic acid residues, preferably more than 70%, with the ratio of R to R being from 1:1 to about 4:1, preferably from 1:1 to about 12:1, and n is an integer from about to 1000. The average mole'cular weight of the copolymer ranges preferably from about 20,000 to about 200,000. Styrene-maleic anhydride copolymer, which is readily hydrolyzable to styrene-maleic acid copolymer, is a commercially available modified styrene-maleic anhydride copolymer. This copolymer can be hydrolyzed to obtain a styrene-maleic acid copolymer which is useful in the present invention. The hydrolysis can be partial or it can be complete and involves a conversion of the acid anhydride linkages to a-dicarboxylic acid units. It is preferred that the hydrolysis be substantially complete, i.e., more than about 50% complete.
Between pH 1 and 2.5 (the pH found in a normal stomach) a styrene-maleic acid copolymer as defined herein is only 0 to 1% ionized and thus is insoluble at this pH, making this copolymer a useful enteric coating for oral pharmaceutical products whose active ingredient is more eflicaciously utilized when absorbed in the intestines rather than the stomach. Other suitable macromolecular polymers are those of the polybasic type (for example, deacetylated chitin, polyvinyl pyridine, styrenevinyl pyridine copolymer, polymeric quaternary ammonium salts), and those of the polyamide type (for eX- ample, polylysine, polyornithine, poly-p-amino-phenylaniline, and polyacrylamide).
Basically, the precoating step of the present invention comprises preparing a mother solution of a liquid phaseforming macromolecular polymer in a non-aqueous liquid; forming a dispersion of liquid or solid hydrophilic material in the mother solution, adding to the thus prepared dispersion a second liquid which is soluble in the first liquid and is a non-solvent to the macromolecular polymer and to the dispersed liquid or solid particles whereby to induce a liquid-liquid phase separation and arated from the liquids, washed, and dried. Optionally,
the precoat can be hardened to impart stability thereto and/ or to reduce permeability.
Various systems suitable for the separation of a macromolecular polymer-rich liquid phase are, the following:
illustratively,
The removal of the equilibrium liquid and the separa tion of the precoated particles thereby is preferably car- Mother solution comprising Phase separation inducing additiveSoluble, Nonsolvent Second Liquid 0 Styrene-maleio acid eopolymer.
Ethanol, Methanol Ethyl acetate, Methyl ethyl ketone, Butyl ketone, Isopropyl ether.
ethyl It was quite unexpectedly discovered that phospholipids can also be used to prepare a non-aqueous mother solution capable of producing a liquid-liquid phase separation and encapsulation. For example the lecithins can be dissolved in chloroform and phase separation induced by the addition of ethanol and/ or acetone.
In each system incipient liquid-liquid phase separation of the macromolecular polymer is manifested, upon the slow mixing of the second liquid miscible with the first liquid, by the appearance of a cloudy condition. The concentrations of first and second liquids at which the cloudy condition first appears will vary with the concentration of the macromolecular polymer dissolved in the first liquid. Said concentrations can be determined for each particular system independent of the presence of the liquid or solid particle to be coated. When so determined, the appropriate concentrations are thereafter used in the presence of the liquid or solid particles to be coated.
The temperature considerations involve those temperatures at which a solution of a suitable concentration of the polymer can be obtained in the first liquid, and the boiling points of the first and second liquids. The ternperature used for the solution, generally, is at least degrees below the boiling point of the lower boiling of the first and second liquids.
The ratio of macromolecular polymer to the liquid or solid particles to be coated is varied with the thickness of the coating desired. Thus, the ratio of the polymer to particle can be varied from about 8 parts by weight of polymer to 1 part by weight of particle, to form about 1 part by weight of polymer to about 8 parts by weight of particle.
Although it is preferred that the liquid and solid particles for coating by phase separation be insoluble in both the first and second liquids, the coating of particles with some or appreciable solubility in either the first or second liquids, or in a mixture thereof, is not outside the concept of the present invention. For example, particles with some solubility in the first liquid can be rendered insoluble, by the addition of the second liquid, prior to the separation of a polymer-rich and a polymer-poor phase.
The setting of the polymer-rich phase after encapsulation to render the phase immobile can be accomplished in various manners. Illustrative, but not limiting, are lowering the temperature; allowing a spontaneous setting by ageing; adding an acid (i.e., a substance capable of accepting a share in a lone electron pair from a base to form a co-ordinate covalent bond) in the case of a polyacidic polymer; adding a base (i.e., a substance capable of donating a share in a lone electron pair to an acid to form a co-ordinate covalent bond) in the case of a polybasic polymer.
ried out prior to the washing of the precoated particles. Said separation is accomplished by centrifugation or filtration. In the case of washing, in situ, the separation of the precoated particles can be carried out by freeze or spray-drying.
For washing the precoated particles in the centrifuge or during filtration, additional amounts of the non-solvent second liquid are used. Said liquid removes traces of the equilibrium liquid and puts the precoated particles in condition for drying.
The drying of the precoated particles can be carried out by simple evaporation, in vacuo, or by the application of heat, depending on the physical characteristics of the non-solvent second liquid.
The hardening of the precoat, as desired, can be carried out by utilizing various methods. Illustrative thereof are the addition of dicarbonyl compounds, alum, tannic acid, and ferric chloride; the removal of occluded liquid by drying and/or heating; by changes in pH; and by the use of the Van de Gratf electron accelerator for irradiation.
After having been precoated and separated, the material is then ready to be coated by phase separation from aque ous medium. The various ways in which coating by phase separation from aqueous medium can be accomplished are conveniently considered with regard to the composition of the coating material or the composition of the mother phase.
In the first method, the mother phase comprises an aqueous solution of a gelable hydrophilic colloid. This method is described in US. Patent No. 2,800,458 and classified as a simple coacervate by H. G. Bungenberg de long and Ong Sian Gwan in Biochemische Zeitschrift 221, 182-205 (1930). By this method an aqueous solution of a gelable hydrophilic colloid, e.g., gelatin, agaragar, albumin, alginates, casein, pectins, and fibrinogen, is prepared at a temperature above the gelling point of the colloid, the precoated particle is suspended in the system, and phase separation is induced by modifying the system with an additive. Such additives include (1) aqueous solutions of electrolytes such as the salts of sodium, potassium, ammonium and lithium cations and sulfate, citrate, acetate and chloride anions or (2) a water-soluble liquid in which the gelable hydrophilic colloid is less soluble than in water such as methanol, ethanol, propanol, acetone and dioxane. A critical concentration exists for each additive in each particular colloid system below which phase separation will not be induced. This concentration is easily determined by routine testing as shown in US. Patent 2,800,458. The colloid-rich phase on separating collects about the surface of the suspended particle, encapsulating the particle with a liquid mantle of the colloid-rich phase. In the absence of the suspended seaaom particle, the colloid-rich phase separates in the form of microscopic droplets which on the addition of the particle will then collect on the particle and encapsulate it. When encapsulation is completed the temperature of the system is lowered below the gelling temperature of the colloid-rich phase thereby changing the colloid mantle from a liquid to a gel. The coated particle can then be removed and/or the coating treated to alter its characteristics.
Another method involves a mother phase comprising an aqueous solution of at least two hydrophilic colloids. This method is described in US. Patent 2,800,457 and classified as complex coacervation by H. G. Bungenberg de long and Ong Sian Gwan in Biochemische Zeitschrift 221, 182-205 (1930). For this method it is essential that at least one of the colloids be gelable and that at least one colloid have an electrophoretic charge opposite from the other(s) in the system. With the preceding requirements in mind, the colloids to be used can be chosen from the various gelable and non-gelable hydrophilic colloids and their derivatives, as, for example, gelatin, agaragar, albumin, alginates, casein, pectins, fibrinogen, starch acetate phthalate, cellulose acetate phthalate, and the like. The optimal concentration of the colloids can be determined by routine testing as described in US. Patent 2,800,457. Phase separation is induced by adjustment of pH and/ or addition of water. The proper pH or amount of Water to be added is easily determined by testing as described in the cited patent.
The coating of the suspended particles then takes place in a similar manner to that described in the first method.
The following remarks are directed to the coatings produced by both the first and second methods.
The gelation step is significant with respect to the permeability of the coating. With many colloid-rich systems, instantaneous gelling of the colloid-rich phase, as by adding the liquid colloid-rich phase to ice water, produces a gelled coating having high permeability. Prolonged cooling also favors a coating of high permeability. The lowest permeability or highest impermeability is obtained with intermediate cooling rates. Thus a highly impermeable coating is produced in the case of gelatin on cooling the newly-formed coating from 50 C. to about C. in a period of approximately 30 minutes with continuous stirring.
Following gelation of the colloid-rich phase, the gelled coating is hardened, plasticized or otherwise treated to adapt it to the intended use. For example, when the colloid-rich phase contains a protein colloid such as gelatin, fibrinogen or collagen, treating the gelled coating with a 37% aqueous solution of formaldehyde under alkaline conditions produces a hardened shell which can then be dried. For most applications, contact of the coating with the said formaldehyde solution for a period of about 10 mintues is productive of a material having sufiicient hardness and resistance to abrasion to withstand the normal usage of packaging or handling. Variations in the hardness of the coating can be obtained by varying the quantity of hardening agent and the period of contact therewith. Hardening likewise has considerable influence on the permeability of the coat, both with respect to the invasion of environmental fluids which would cause disintegration of the coating and to the containment of active ingredients.
Hardening can be accomplished by a drying process. By removing the water occluded within the mantle, the mantle is hardened. The drying can be accomplished by exposure to hot air or other methods such as containment within a closed vessel which contains a desiccant.
Another method of coating by phase separation employs an aqueous solution of a synthetic linear macromolecular polymer whose polymer units comprise both lipophilic and hydrophilic units. Thus, one class of recurring polymer unit is essentially lipophilic in character, e.g., one derived from styrene, an alkyl ring substituted styrene,
ether, ester or halogen ring substituted styrene, an ether or ester substituted ethylene; and the other major recurring unit is essentially hydrophilic in character, e.g., derived from maleic acid, maleic acid amide, acrylic acid, crotonic acid, and acrylic acid amide. In combination, these lipophilic and hydrophilic units preferably comprise .a majority of the polymeric units present in the polymer. Other polymer units may also be present in the copolymer, so long as they are present in minor amounts, i.e., less than either the hydrophilic or lipophilic polymer units. Included among these polymers are the hydrolyzed styrene-maleic anhydride copolymers, styrene-maleic acid amide polymer, the sulfonated polystyrenes, the carbohydrate acetate phthalates (e.g., starch acetate phthalate. cellulose acetate phthalate and amylose acetate phthalate), polymethacrylic acid, and methyl vinyl ether-maleic acid copolymer.
Preferred among the polymers employed by this method are the hydrolyzed styrene-maleic anhydride copoly- :mers the anhydride groups of which are preferably at least 50% hydrolyzed. The copolymer can also contain other polymer units in minor amounts, e.g., those derived from acrylonitrile, acrylic acid, methacrylic acid, itaconic acid, ethyl vinyl ether, methyl vinyl ether, vinyl chloride, vinylidene chloride, etc., and the like.
The solubility of the polymers employed by this method vary considerably in a selected aqueous liquid. For example, completely hydrolyzed styrene-maleic anhydride polymer is about 2% soluble in water but at least 20% soluble in a 50:50 mixture of methanol and water. Thus, solutions of the desired polymer can be prepared in relatively dilute form in water alone. Alternatively, the concentration of the polymer can be increased by the addition of a solubilizing agent, e.g., another hydrophilic liquid such as, for example, methanol or ethanol. Another type of solubilizing agent useful when carboxylic acid polymers are employed are the polysaccharides, e.g. alginates, pectins, methylcellulose, carboxymethylcellulose, etc. Of particular usefulness are the galactose polysaccharides, e.g., carrageen (derived from Irish moss), available as Sea Kem Type No. 1 from Seaplant Chemical Corporation, New Bedford, Massachusetts. For example, the solubility of completely hydrolyzed styrene-maleic anhydride copolymer in water can be raised from about 2% to about 7 to 10% in the presence of relatively small amounts of this polysaccharide, e.g., one part to four parts of the copolymer. Higher concentrations of the acid polymers can also be achieved by passing a solution of an alkali-metal salt thereof through a bed of sulfonic acid ion exchange resin, e.g., Dowex 50.
Phase separation is induced by the addition of a solution of a suitable electrolyte as salts of magnesium, ammonia, potassium and lithium cations and sulfate, phosphate, citrate, acetate, chloride, bromide, thiocyanate and nitrate anions. The salt should be added in amounts sufiicient to produce a significant pcrcetage thereof by weight per volume of the resulting mixture, e.g., l to 50% and preferably 3 to 20%.
The proper amount of additive for inducing phase separation is readily determined beforehand by the addition of increasing amounts of the selected additive to a previous solution of the polymer, identical with that to be employed in the encapsulation process, until phase separation occurs in an appreciable amount. This is observable as a visible clouding of the solution.
In carrying out the process of this method, the selected polymer is dissolved in the selected aqueous medium, the precoated material is suspended therein, and phase separation is induced by a suitable additive. A polymerrich liquid phase separates and encapsulates the suspended particle.
In the next step of the process, the pH of the system containing the encapsulated product is adjusted so as to reduce the solubility of the mantle of the thus-produced encapsulated product in the aqueous solvent. If the start ing polymer is acidic in character, then the solution is made acidic. Conversely, if the polymer is basic in character, the solution is made basic. In general, it can be said that in this step, the ionizing properties of the mantle are reduced, thus reducing its afiinity towards the aqueous solvent. The correct pH can be determined by visual means, either by observing a change in the appearance of the encapsulated product or by observing the particles under a microscope. The mantle or polymer-rich phase as it forms has a somewhat transparent appearance, where as when it is converted to isolatable form by adjustment of the pH, it becomes more opaque or translucent.
Any strong acid or base can be employed to adjust the pH, e.g., hydrochloric acid, sulfuric acid and sodium or potassium hydroxide.
This method is thus different from methods 1 and 2, both in the material used and the step by which an isolatable encapsulated product is produced. In the first and second methods, the critical step in producing an isolatable product is the step of chilling to below the gelation temperature of the gelable colloid employed. In the in stant method, gelability is not a critical characteristic of the polymer employed. Instead, the combination of lipophilic and hydrophilic polymer units in the polymer enable the polymer to encapsulate while at the same time having ionizing properties which can be altered by the adjustment of the pH of the aqueous solvent. Thus when the polymer mantle is formed, it is fixed by adjusting the pH of the aqueous solution in which the encapsulated product is suspended, thereby producing a mantle which is rigid enough to separate the encapsulated product from the suspending liquid.
The thus-produced encapsulated product can be isolated by centrifugation of filtration to remove the aqueous liquid and then washing the encapsulated material, e.g., with water, but avoiding such vigorous washing as will redissolve a significant amount of the polymer mantle. Alternatively, the total reaction product can be freezedried or dried at from about room temperature to about 60 C., e.g., under vacuum The mantle of the encapsulated product can be further hardened by exposure to reagents which will chemically alter the surface groups of the polymer mantle, e.g., the polymer can be reacted with a monomer to produce cross'linking or reacted with a salt containing a polyvalent cation, e.g., aluminum sulfate or barium chloride, when the structure of the polymer permits.
Still another method of coating by phase separation employs an aqueous solution of a styrene-maleic acid copolymer capable of having an electrophoretic charge (of the type described in the preceding method) and a gelable hydrophilic colloid which is of opposite charge at the pH at which significant phase separation takes place.
The aqueous solutions which can be employed in the process of this method include water solutions and aqueous solutions which comprise water and a water-soluble hydroxy compound such as a lower alkanol, e.g., methanol and ethanol; a lower alkylene glycol, e.g., ethylene glycol, propylene glycol and trimethylene glycol; a lower alkyl triol, e.g., glycerol; and mixtures thereof.
The glycols and triols as defined above are also useful additives to prevent coalescence of the encapsulated product and to produce a product having superior handling properties. Examples of other anti-coalescing agents are the polyethylene glycols 200 to 600.
Either separately or together with the copolymer, a solution of the selected colloid, e.g., gelatin, agar-agar, albumin, alginates, casein, pectins and chitosans, is prepared. Sometimes, e.g., when it is ditficult to stay outside the condition under which phase separation occurs, it is preferred to prepare a solution of the copolymer and a solution of the colloid separately. Ordinarily it is necessary to adjust the pH of one or both of the solutions to prevent phase separation when they are mixed. Alternatively, a mixture of the colloids, copolymer and the selected aqueous solvent can be heated, e.g., to above the 10 gel temperature of the colloid and the pH adjusted until phase separation occurs.
The precoated material is suspended in the mother phase and the phase separation induced by adjusting the pH. The correct pH for inducing phase separation is readily determined by adding acid or base to a clear solution of a mother phase until clouding occurs, similar to the trial procedures in the previous methods.
In the presence of the suspended particles, the separating copolymer-colloid-rich phase coatsthe particle, forming a mantle thereover, thus producing the encapsulated product.
At this stage, the mantle is ordinarily still quite mobile and not amenable to isolation. However, the mantle is, to a degree, self-hardening and will produce a more stable mantle upon standing, preferably from 30 minutes to several hours or days at a temperature above the gelation temperature of the colloid. Techniques well known in the tanning art for the tanning of hides, can be employed to accelerate this autohardening, e.g., suspending the encapsulated product for 15 minutes in 10% aqueous ferric chloride or 10% tannic acid in isopropyl alcohol, or in 10% aqueous ferric chloride for 15 minutes at room temperature and then in 20% tannic acid in glycerin.
Alternatively, other hardening agent or agents can be added to the total mixture containing the encapsulated product. Preferred are the highly active carbonyl compounds, especially those having from one to 8 carbon atoms, inclusive. Examples of these are formaldehyde glyoxal, phenylglyoxal, malonic acid dialdehyde, pyruvaldehyde, glyceraldehyde, diacetyl and methyl phenyl ketone. Heating will sometimes accelerate the hardening process, but care should be taken not to disrupt the still mobile mantle.
Alternatively, the encapsulated product can be hardened by exposure to reagents which will chemically alter the surface groups of the polymer mantle, e.g., the poly mer can be reacted with a monomer to produce crosslinking, when the structure of the polymer permits, or irradiated, e.g., with high velocity electron bombardment, e.g., with a Van de Grai'f electro generator, to change the molecular structure of the monomer and, desirably to concomitantly sterilize the encapsulated material.
The thus-produced encapsulated product can be isolated by centrifugation or filtration to remove the aqueous liquid and then washing the encapsulated material thoroughly, e.g., with water or dilute acid, e.g., dilute acetic acid, and then dried, e.g., freeze or spray dried.
The following examples are illustrative of the process and products of the present invention and are not to be construed as limiting.
Example 1 15 milliliters of a 0.5%, w./v., aqueous solution of amaranth is added with vigorous agitation to milliliters of a 5.0%, w./v., solution of cellulose acetate butyrate in methylethyl ketone. This mixture is then passed through a hand homogenizer three times. Enough additional butyrate solution is added through the homogenizer to make 150 ml. of emulsion.
The emulsion is then heated to 55 C. on a steam bath while being stirred rapidly. An additional 15 m1. of amaranth solution is added at this time. I
To the emulsion system isopropyl ether previously heated to 50 C. is added in small portions with agitation. An increased cloudiness is noted when ml. had been added. The presence of liquid phase-coated water droplets can be confirmed by microscopic examination.
Therefore an additional 10 ml. of isopropyl ether is added with stirring to produce more liquid phase separation. The mixture is allowed to cool slowly without agitation. The coated particles are separated by centrifugation, washed with isopropyl ether and dried in vacuo.
A solution of 50 gm. of gelatin in 450 ml. of water is prepared at from about 40 to 50 C. The precoated amaranth solution is added to this system, with adequate stirring to maintain the particles uniformly suspended. With stirring and with the temperature maintained at from about to C., ethanol (95%) is slowly added to the system. When the concentration of ethanol reaches about 50% v./v., the gelatin-rich phase separates and encapsulates the suspended particles. When the ethanol concentration reaches about v./v., the whole mixture is cooled to from about 2 to 6 C. to gel the gelatin coating. The coated material is separated from the bulk of the residual liquid, advantageously by centrifuging. Thereafter the coated amaranth solution is washed thoroughly by suspending in 2000 ml. of water and then removed by centrifuge and dried.
Example 2 A solution of 10 gm. of benzyl cellulose is prepared at about 40 C. in 300 ml. of trichloroethylene. About gm. of finely divided sodium(2,4-dichlorophenoxy)acetate is suspended in the system with adequate stirring. With stirring and with the temperature maintained at about 40 C., propanol is added. When the concentration of propanol reaches about 51% v./v., a benzyl-cellulose-rich phase separation occurs and the sodium(2,4-dichlorophenoxy)acetate particles are coated by the separating phase. The whole mixture is cooled to room temperature. Thereafter, the precoated material is separated, by centrifuging, thoroughly washed with propanol, and allowed to dry.
A solution of 100 gm. of gelatin in 900 ml. of water is prepared at from about 40 to 50 C. The precoated sodium(2,4-dichlorophenoxy) acetate is added to this system, with adequate stirring to maintain the particles uniformly suspended. With stirring and with the temperature maintained at from about 40 to 50 C., ethanol is slowly added to the system. When the concentration of ethanol reaches about 50% v./v., the gelatin-rich phase separates and encapsulates the suspended particles. When the ethanol concentration reaches about 55% v./v., the whole mixture is cooled to from about 2 to 6 C. to gel the gelatin coating. The coated material is separated from the bulk of the residual liquid, advantageously by centrifuging. Thereafter the coated sodium(2,4-dichlorophenoxy)acetate is washed thoroughly by suspending in 2000 ml. of water and then removed by centrifuge and dried.
The coated sodium(2,4-dichlorophenoxy)acetate in the form of a dry powder can be placed in commerce for later suspension in water to be usefully applied as a slow release weed control.
Example 3 A solution of 50 gm. of cellulose acetobutyrate is prepared in 1000 ml. of methyl ethyl ketone at about 55 C. About 12.5 gm. of powdered dibasic calcium phosphate is dispersed in the solution with adequate stirring to maintain the phosphate particles uniformly suspended. With stirring and with the temperature maintained at about 50 C., isopropyl ether is added. When the concentration of the ether reaches about 42% v./v., a polymer-rich phase separates and coats the phosphate particles. The system is cooled to room temperature. Thereafter, the precoated phosphate particles are separated, advantageously by centrifuging, washed with isopropyl ether and allowed to dry.
A solution of 50 gm. of pork skin gelatin in 450 ml. of water is prepared at from about 40 to 50 C. The precoated phosphate particles are added to the system, with adequate stirring to maintain the particles uniform- 1y suspended. With stirring and with the temperature maintained at from about 4 to 50 C., ethanol (95%) is slowly added to the system. When the concentration of ethanol reaches about 50% v./v., phase separation is induced and the separating colloid-rich phase encapsulates the dispersed precoated phosphate particles. When the ethanol concentration reaches about 55% v./v., the whole mixture is cooled to below 10 C. to gel the colloid-rich phase. The coated dibasic calcium phosphate is separated from the bulk of the residual liquid, advantageously by centrifuging. Thereafter the coated material is washed thoroughly by suspending in 2000 ml. of water and then removed by centrifuge and dried.
The coated particles of dibasic calcium phosphate are usefully applied to the soil for use as a slow release fertilizer.
Example 4 About 20 gm. of ethyl cellulose are dissolved in a mixture of 400 ml. of xylene and 80 ml. of ethanol. About 5 gm. of microcrystalline ascorbic acid are suspended in the solution and 500 ml. of Skellysolve B (ii-hexane) is added dropwise whereby phase separation is induced. The system is spray dried and the precoated ascorbic acid particles collected.
Twenty-five grams of styrene-maleic acid copolymer are dissolved in about 1250 ml. of water and heated to 80 C. The precoated ascorbic acid particles are suspended in the solution. With constant stirring of the suspension, 275 ml. of a 20% sodium sulfate solution, heated to 80 C. are added dropwise (upon addition of the sodium sulfate solution; phase separation is induced and encapsulation of the particles takes place). The suspension is maintained at 80 C. for 20 minutes.
About 250 ml. of glacial acetic acid is mixed with about 2500 ml. of 20% sodium sulfate aqueous solution and cooled to about 5 C. With vigorous stirring, the suspension is slowly added to the cool, acidified sodium sulfate solution.
The coated ascorbic acid particles are removed by cen trifugation and washed several times by alternatively suspending in Water and separating by centrifugation. As a final step the particles are suspended in 500 ml. of water and freeze dried.
The coated particles of ascorbic acid are usefully administered to animals (including humans) as a therapeutic or prophylactic treatment. The particles can be suspended in aqueous solutions of the Water-soluble vitamins, including cyanocobalamin, the protective coating preventing the degradation of cyanocobalarnin by ascorbic acid.
Example 5 A solution is prepared with 10 gm. of styrene-maleic acid copolymer and ml. of ethanol. About 80 gm. of powdered pancreatin are dispersed in the solution. With continuous stirring, ethylbutyl ketone is added to the suspension until a concentration of about 60% v./v. is attained. As a result of the addition of ketone, phase separation and encapsulation of the suspended pancreatin occurs. The precoated pancreatin is recovered, Washed with butylethyl ketone and dried.
Twenty-seven grams of acacia powder are dissolved in 167 ml. of water heated to 40 C. When the acacia has dissolved, a sufficient amount of a 20% acetic acid solution is added to give a pH of 3.9. The temperature of the solution is maintained at 40 C.
Twenty grams of gelatin are dissolved in 167 ml. of water heated to 40 C. When the gelatin has dissolved, a sufiicient amount of a 20% acetic acid solution is added to give a pH of 3.9. The temperature of the solution is maintained at 40 C.
The precoated particles of pancreatin are dispersed in the acacia solution and the gelatin solution is slowly added with stirring. About 415 ml. of water, previously heated to 40 C. is added dropwise to bring about separation of the colloid-rich phase which encapsulates the suspended pancreatin particles. The mixture is maintained at 40 C. for about 20 minutes and then cooled over a period of about 30 minutes to about 4 C. The mixture is maintained below 6 C. for one hour. The pH of the mixture is adjusted to 9.5 by the addition of 10% sodium hy- 13 droxide solution and about 20 ml. of a 30% glyoxal solution is added dropwise. The solution is maintained below 6 C. for an additional one hour and then allowed to warm to room temperature. The coated particles are removed by centrifugation.
The particles are twice washed by dispersing in 1000 ml. of water and Separated by centrifugation. The particles are then redispersed in 1000 ml. of water and spray dried.
The coated pancreatin is thus protected after oral ingestion from the destructive action of the acidic stomach juices.
Example 6 About 40 gm. of micronized methylscopolamine hydrobromide are suspended in 500 ml. of a w./v. solution of cellulose acetate butyrate in methylethyl ketone. The suspension is heated to- 55 C. and 350 ml. of isopropyl ether added dropwise to the system with continuous stirring. The system is cooled slowly to room temperature and the precoated methylscopolamine hydrobromide par- 'ticles separated by centrifugation, Washed with isopropyl ether and dried in vacuo.
About 20 gm. of styrene-maleic acid copolymer and about 5 gm. of Sea Kern, Type No. 1 are mixed and-dis- 'persed in 100 ml. of propylene glycol. About 500 ml. of water are added to the dispersion and heated to 80 C. to dissolve. The precoated methylscopolamine hydrobromide particles are suspended in the solution and a solution of about 20 gm. of gelation dissolved in 100 ml. of water at 800 C. is added dropwise. The suspension is maintained at 80 C. with stirring for minutes and then cooled to 4 C. over a period of 30 minutes. The suspension is maintained at 4 C. for one hour and then about ml. of 37% aqueous formaldehyde solution is added and the pH adjusted to pH 8.0 with a su'fiicient amount of 10% aqueous sodium hydroxide solution. The suspension is maintained at 4 C. for one hour and then the encapsulated urea removed by centrifugation. The encapsulated particles are resuspended in 1% hydrochloric acid solution and spray dried.
Example 7 Seventy-five grams of micronized ferrous sulfate, exsiccated, U.S.P. is suspended with constant agitation to 1250 ml. of a 20% (w./v.) solution of lecithin (centrolex H) in chloroform and heated to 50 C. Fifteen hundred milliliters of a 50:50 (v./v.) solution of ethanol and acetone is added slowly and with stirring to the suspension (upon the addition of the ethanol-acetone solution phase separation occurs and encapsulation of the ferrous sulfate particles takes place). The system is cooled to at least 20 C. and filtered. The precoated ferrous sulfate particles are removed from the filter and dispersed in 1000 cc. of acetone at room temperature. The surface of the lecithin precoat is treated by the addition of 1000 cc. of a saturated solution of aluminum chloride in 95% ethanol. The suspension is stirred for minutes and the precoated ferrous sulfate removed by filtration and air dried.
Twenty-seven grams of acacia powder are dissolved in 167 ml. of water heated to C. When the acacia has dissolved, a sufficient amount of a 20% acetic acid solution is added to give a pH of 3.9. The temperature of the solution is maintained at 40 C.
Twenty grams of gelatin are dissolved in 167 ml. of water heated to 40 C. When the gelatin has dissolved, a sufiicient amount of a 20% acetic acid solution is added to give a pH of 3.9. The temperature of the solution is maintained at 40 C.
The precoated ferrous sulfate is dispersed in the acacia solution and the gelatin solution is slowly added with stirring. About 415 ml. of water, previously heated to 40 C. is added dropwise to bring about separation of the colloid-rich phase which coats the wax-coated methionine. The mixture is maintained at 40 C. for
about 20 minutes and then cooled over a period of about 30 minutes to about 4 C. The mixture is maintained below 6 C. for about one hour. The pH of the mixture is adjusted to 9.5 by the addition of 10% sodium hydroxide solution and about 20 ml. of a 30% glyoxal solution is added dropwise. The solution is maintained below 6 C. for an additional 2 hours and then allowed to warm to room temperature. The coated particles of ferrous sulfate are removed by centrifugation.
The particles are washed twice by dispersing in 1000 ml. of water and separated by centrifugation. The particles are then redispersed in 1000 ml. of water and spray dried.
It is to be understood that this invention is not to be limited to the exact details of operation of exact compo- 'sitions shown and described, as obvious modifications and equivalents will be apparent to one skilled in the art, and the invention is therefore to be limited only by the scope of the appended claims.
What is claimed is:
1. A process for the coating en masse of a plurality of individual discrete fluid and solid particles of hydrophilic matter which comprises: (1) preparing a solution of a liquid phase forming macromolecular polymer in a first nonaqueous liquid; (2) dispersing in said solution a plurality of individual discrete particles selected from the group consisting of insoluble fluid hydrophilic particles and insoluble solid hydrophilic particles; (3) adding a second liquid, solublein the first liquid and non-solvent for said macromolecular polymer and said dispersed particles, whereby phase separation is induced and the separating phase precoats each of the dispersed particles; (4) setting the polymer-rich precoat; (5) separating said precoated particles; (6) suspending the precoated particles in an aqueous solution of a gelable hydrophilic colloid; (7) inducing phase separation, whereby to cause the formation of a colloid-rich phase and the encapsulation of each of the suspended precoated particles, the foregoing steps (6) and (7) being carried out at a temperature above the gelatin point of the colloid material; and (8) gelling the colloid-rich phase by cooling.
2. The process of claim 1 wherein the coated particles are separated and thereafter the coating is dried.
3. The process of claim 1 wherein the coated particles are (1) separated, and (2) the coating material is dried and hardened.
4. A process for the coating en masse of a plurality of individual discrete fluid and solid particles of hydrophilic matter which comprises: (1) preparing a solution of a liquid phase forming macromolecular polymer in a first non-aqueous liquid; (2) dispersing in said solution a plurality of individual discrete particles selected from the group consisting of insoluble fluid hydrophilic particles and insoluble solid hydrophilic particles; (3) adding a second liquid, soluble in the first liquid and non-solvent for said macromolecular polymer and said dispersed particles, whereby phase separation is induced and the separating phase precoats each of the dispersed particles; (4) setting the polymer-rich precoat; (5) separating said precoated particles; (6) suspending the precoated particles in an aqueous solution of at least twocolloids, at least one of which is gellable and one of which has the opposite electrophoretic charge from the remaining colloids; (7) inducing phase separation, whereby to cause the formation of a colloid-rich phase and the encapsulation of each of the suspended precoated particles, the foregoing steps (6) and (7) being carried out at a temperature above the gelation point of the gellable colloid; and (8) gelling the colloid-rich phase by cooling.
5. The process of claim 4 wherein the coated particles are separated and thereafter the coating is dried.
6. The process of claim 4 wherein the coated particles are (1) separated, and (2) the coating material is dried and hardened.
7. A process for the coating en masse of a plurality of individual discrete fluid and solid particles of hydrophilic matter which comprises: (1) preparing a solution of a liquid phase forming macromolecular polymer in a first non-aqueous liquid; (2) dispersing in said solution a plurality of individual discrete particles selected from the group consisting of insoluble fluid hydrophilic particles and insoluble solid hydrophilic particles; (3) adding a second liquid, soluble in the first liquid and nonsolvent for said macromolecular polymer and said dispersed particles, whereby phase separation is induced and the separating phase precoats each of the dispersed particles; (4) setting the polymer-rich precoat; (5) separating said precoated particles; (6) suspending the precoated particles in an aqueous solution of a linear macromolecular synthetic polymer,- a majority of whose polymer units comprise both lipophilic and hydrophilic units; (7) inducing phase separation, whereby to cause the formation of a polymer-rich phase and the encapsulation of each of the suspended precoated particles; (8) adjusting the pH of the solution whereby to reduce the solubility of the polymer and to rigidity the polymer rich phase.
8. A process for the coating en masse of a plurality of individual discrete fluid and solid particles of hydrophilic matter which comprises: (1) preparing a solution of a liquid phase forming macromolecular polymer in a first non-aqueous liquid; (2) dispersing in said solution a plurality of individual discrete particles selected from the group consisting of insoluble fluid hydrophilic particles and insoluble solid hydrophilic particles; (3) adding a second liquid, soluble in the first liquid and nonsolvent for said macromolecular polymer and said dispersed particles, whereby phase separation is induced and the separating phase precoats each of the dispersed particles; (4) setting the polymer-rich precoat; (5) separating said precoated particles; (6) suspending the precoated particles in an aqueous solution of an electrophoretically chargeable styrene-maleic acid copolymer and an oppositely electrophoretically chargeable gellable colloid at a pH outside the range which induces liquid phase separation; (7) inducing phase separation by the adjustment of a pH whereby to cause the formation of a colloidcopolymer rich phase and the encapsulation of each of the suspended precoated particles, the foregoing steps (6) and (7) being carried out at a temperature above the gelation point of the gellable colloid; (8) rigidifying the colloid-copolymer rich phase, whereby an isolatable encapsulated product is produced, by at least one of the steps of (a) cooling to a temperature of the colloid and (b) adding to the system a highly active carbonyl compound.
9. A process for coating en masse individual discrete particles of water soluble solid material which comprises: (1) preparing a solution of ethylcellulose in a solvent system comprising a major portion of Xylene and a minor portion of ethanol;
(2) suspending in the saidsolution individual discrete particles of water soluble solid material;
(3) inducing phase separation by means of the addition of n-hexane to the said solution whereby phase separation is induced and the separating phase envelopes individually and precoats individually each of the suspended discrete particles of water soluble solid material;
(4) spray drying the system whereby the individual precoated particles are obtained in a discrete dry condition;
(5) preparing asolution of styrene-maleic acid copolymer and water, said solution being at about 80 C.; (6) suspending the discrete precoated particles in the aqueous styrene-maleic acid copolymer solution;
(7) inducing phase separation by means of the dropwi e addit on of an q eous sodium sulfate solution heated to about C. whereby phase separation is induced and the separating phase envelopes individually and coats individually each of the suspended precoated particles;
(8) maintaining the system at about 80 C. for about 20 minuts;
(9) pouring the system with vigorous stirring into a solution of water, sodium sulfate and glacial acetic acid having a temperature of about 5 C.;
(10) separating out the individually coated discrete particles;
(11) washing the coated particles with water; and
(12) freeze drying the coated particles.
10. A process for coating en masse individual discrete particles of microcrystalline ascorbic acid which comprises:
(1) preparing a solution of ethylcellulose in a solvent system comprising a major portion of xylene and a minor portion of ethanol;
(2) suspending in the said solution individual discrete particles of microcrystalline ascorbic acid;
(3) inducing phase separation by means of the addition of n-hexane to the said solution whereby phase separation is induced and the separating phase envelopes individually and precoats individually each of the suspended discrete particles of ascorbic acid;
(4) spray drying the system whereby the individual precoated particles of ascorbic acid are obtained in a discrete dry condition;
(5) preparing a solution of styrene-maleic acid copolymer and water,- said solution being at about 80 C.;
(6) suspending the discrete precoated particles of ascorbic acid in the aqueous styrene-maleic acid copolymer solution;
(7) inducing phase separation by means of the dropwise addition of an aqueous sodium sulfate solution heated to about 80 C. whereby phase separation is induced and the separating phase envelopes individually and coats individually each of the suspended precoated particles of ascorbic acid;
(8) maintaining the system at about 80 C. for about 20 minutes;
(9) pouring the system with vigorous stirring into a solution of water, sodium sulfate and glacial acetic acid having a temperature of about 5 C.;
(10) separating out the individually coated discrete particles of ascorbic acid; 1
(11) washing the coated particles of ascorbic acid with water; and
ascorbic (12) freeze drying the coated particles of acid.
References Cited by the Examiner UNITED STATES PATENTS 2,333,283 11/1943 Wilson 167--83 2,585,903 2/1952 Meyer 16783 XR 2,770,571 11/1956 Vance et al 16783 2,800,457 7/1957 Green et al. 252--316 2,800,458 7/1957 Green 252-3 16 2,844,512 7/1958 Eble 167-83 2,897,121 7/1959 Wagner 167-82 2,897,122 7/1959 Millar 167-82 2,969,331 1/1961 Brynko et al. '152316 OTHER REFERENCES Bungenberg de Jong et al.: Biochemische Zeitschrift,
vol. 221, pages 182-205 (1930).
JULIUS GREENWALD, Primary Examiner.
JOSEPH R. LIBERMAN, Examiner.
R. D. LOVERING, Assistant Examiner,
Claims (2)
1. A PROCESS FOR THE COATING EN MASSE OF A PLURALITY OF INDIVIDUAL DISCRETE FLUID AND SOLID PARTICLES OF HYDROPHILIC MATTER WHICH COMPRISES: (1) PREPARING A SOLUTION OF A LIQUID PHASE FORMING MACROMOLECULAR POLYMER IN A FIRST NON-AQUEOUS LIQUID; (2) DISPERSING IN SAID SOLUTION A PLURALITY OF INDIVIDUAL DISCRETE PARTICLES SELECTED FROM THE GROUP CONSISTING OF INSOLUBLE FLUID HYDROPHILIC PARTCLES AND INSOLUBLE SOLID PHDROPHILIC PARTICLES; (3) ADDING A SECOND LIQUID, SOLUBLE IN THE FIRST LIQUID AND NON-SOLVENT FOR SAID MACROMOLECULAR POLYMER AND SAID DISPERSED PARTICLES, WHEREBY PHASE SEPARATION IS INDUCED AND THE SEPARATING PHASE PRECOATS EACH OF THE DISPERSED PARTICLES; (4) SETTING THE POLYMER-RICH PRECOAT; (5) SEPARATING SAID PRECOATED PARTICLES; (6) SUSPENDING THE PRECOATED PARTICLES IN AN AQUEOUS SOLUTION OF A GELABLE HYDROPHILIC COLLOID; (7) INDUCING PHASE SEPARATION, WHEREBY TO CAUSE THE FORMATION OF A COLLOID-RICH PHASE AND THE ENCAPSULATION OF EACH OF THE SUSPENDED PRECOATED PARTICLES, THE FOREGOING STEPS (6) AND (7) BEING CARRIED OUT AT A TEMPERATURE ABOVE THE GELATIN POINT OF THE COLLOID MATERIAL; AND (8) GELLING THE COLLOID-RICH PHASE BY COOLING.
10. A PROCESS FOR COATING EN MASSE INDIVIDUAL DISCRETE PARTICLES OF MICROCRYSTALLINE ASCORBIC ACID WHICH COMPRISES: (1) PREPARING A SOLUTION OF ETHYLCELLULOSE IN A SOLVENT SYSTEM COMPRISING A MAJOR PORTION OF XYLENE AND A MINOR PORTION OF ETHANOL; (2) SUSPENDING IN THE SAID SOLUTION INDIVIDUAL DISCRETE PARTICLES OF MICROCRYSTALLINE ASCORBIC ACID; (3) INDUCING PHASE SEPARATION BY MEANS OF THE ADDITION OF N-HEXANE TO THE SAID SOLUTION WHEREBY PHASE SEPARATION IS INDUCED AND THE SEPARATING PHASE ENVELOPED INDIVIDUALLY AND PRECOATS INDIVIDUALLY EACH OF THE SUSPENDED DISCRETE PARTICLES OF ASCORBIC ACID; (4) SPRAY DRYING THE SYSTEM WHEREBY THE INDIVIDUAL PRECOATED PARTICLES OF ASCORBIC ACID ARE OBTAINED IN A DISCRETE DRY CONDITION; (5) PREPARING A SOLUTION OF STYRENE-MALEIC ACID COPOLYMER AND WATER, SAID SOLUTION BEING AT ABOUT 80*C.; (6) SUSPENDING THE DISCRETE PRECOATED PARTICLES OF ASCORBIC CID IN THE AQUEOUS STYRENE-MALEIC ACID COPOLYMER SOLUTION; (7) INDUCING PHASE SEPARATION BY MEANS OF THE DROPWISE ADDITION OF AN AQUEOUS SODIUM SULFATE SOLUTION HEATED TO ABOUT 80*C. WHEREBY PHASE SEPARATION IS INDUCED AND THE SEPARATING PHASE ENVELOPES INDIVIDUALLY AND COATS INDIVIDUALLY EACH OF THE SUSPENDED PRECOATED PARTICLES OF ASCORBIC ACID; (8) MAINTAINING THE SYSTEM AT ABOUT 80*C. FOR ABOUT 20 MINUTES; (9) POURING THE SYSTEM WITH VIGOROUS STIRRING INTO A SOLUTION OF WATER, SODIUM SULFATE AND GLACIAL ACETIC ACID HAVING A TEMPERATURE OF ABOUT 5*C.; (10) SEPARATING OUT THE INDIVIDUALLY COATED DISCRETE PARTICLES OF ASCORBIC ACID; (11) WASHING THE COATED PARTICLES OF ASCORBIC ACID WITH WATER; AND (12) FREEZE DRYING THE COATED PARTICLES OF ASCORBIC ACID.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US781917A US3242051A (en) | 1958-12-22 | 1958-12-22 | Coating by phase separation |
GB36637/59A GB931150A (en) | 1958-12-22 | 1959-10-28 | A process for the two-fold encapsulation of hydrophilic material by phase separation |
CH8206459A CH396847A (en) | 1958-12-22 | 1959-12-19 | Process for coating hydrophilic materials |
FR813669A FR1334917A (en) | 1958-12-22 | 1959-12-21 | Coating process for liquid and solid hydrophilic materials |
DEU6765A DE1185155B (en) | 1958-12-22 | 1959-12-22 | Process for the production of spheres containing hydrophilic substances inside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US781917A US3242051A (en) | 1958-12-22 | 1958-12-22 | Coating by phase separation |
Publications (1)
Publication Number | Publication Date |
---|---|
US3242051A true US3242051A (en) | 1966-03-22 |
Family
ID=25124366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US781917A Expired - Lifetime US3242051A (en) | 1958-12-22 | 1958-12-22 | Coating by phase separation |
Country Status (4)
Country | Link |
---|---|
US (1) | US3242051A (en) |
CH (1) | CH396847A (en) |
DE (1) | DE1185155B (en) |
GB (1) | GB931150A (en) |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3336155A (en) * | 1964-01-15 | 1967-08-15 | Ncr Co | Process of coating particles with a polymer |
US3404093A (en) * | 1965-03-29 | 1968-10-01 | Magnaflux Corp | Fluorescent composition for magnetic particle inspection |
US3405071A (en) * | 1963-12-30 | 1968-10-08 | Ibm | Process of making microcapsules |
US3483132A (en) * | 1966-06-01 | 1969-12-09 | Gen Electric | Bubble dissolution control by film formation |
US3539377A (en) * | 1968-05-07 | 1970-11-10 | Us Army | Method for coating oxidizer particles with a polymer |
US3875074A (en) * | 1972-03-06 | 1975-04-01 | Champion Int Corp | Formation of microcapsules by interfacial cross-linking of emulsifier, and microcapsules produced thereby |
US3878121A (en) * | 1971-12-28 | 1975-04-15 | Poudres & Explosifs Ste Nale | Method of encapsulation by coacervation, and the substances obtained |
US3951851A (en) * | 1972-05-29 | 1976-04-20 | Fuji Photo Film Co., Ltd. | Process of producing aspirin-containing capsules |
US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
US4107071A (en) * | 1977-02-16 | 1978-08-15 | Capsulated Systems, Inc. | Method of producing microcapsules and resulting product |
US4110511A (en) * | 1977-05-25 | 1978-08-29 | The Mead Corporation | Process for the production of a pressure-sensitive carbonless copy sheet using microcapsules formed in situ in a radiation curable binder |
US4230495A (en) * | 1979-02-26 | 1980-10-28 | The Mead Corporation | Process for producing a pressure-sensitive carbonless copy sheet using microcapsules formed in situ in a radiation curable binder |
US4282255A (en) * | 1979-06-28 | 1981-08-04 | State Of Oregon, By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Method and starter compositions for the growth of acid producing bacteria and bacterial compositions produced thereby |
US4353962A (en) * | 1980-05-15 | 1982-10-12 | Environmental Chemicals, Inc. | In-flight encapsulation of particles |
US4389331A (en) * | 1979-10-31 | 1983-06-21 | Tanabe Seiyaku Co., Ltd. | Process for preparing pharmaceutically active compound-containing microcapsules |
US4435383A (en) | 1980-09-05 | 1984-03-06 | E. I. Du Pont De Nemours And Company | Slow release pesticide formulations |
WO1985000105A1 (en) * | 1983-06-22 | 1985-01-17 | Ohio State University Research Foundation | Small particle formation and encapsulation |
US4532123A (en) * | 1982-03-04 | 1985-07-30 | Battelle Development Corporation | Dual Microcapsules and process for their preparation |
US4557929A (en) * | 1981-07-22 | 1985-12-10 | E. I. Du Pont De Nemours And Company | Slow release pesticide formulations |
USRE32079E (en) * | 1979-06-28 | 1986-02-04 | State Of Oregon, By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Method and starter compositions for the growth of acid producing bacteria and bacterial compositions produced thereby |
US4606940A (en) * | 1984-12-21 | 1986-08-19 | The Ohio State University Research Foundation | Small particle formation and encapsulation |
US4637905A (en) * | 1982-03-04 | 1987-01-20 | Batelle Development Corporation | Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones |
EP0296106A2 (en) * | 1987-06-16 | 1988-12-21 | Ciba-Geigy Ag | Organic pigments coated with metal oxides fixed by ethyl cellulose |
US4830855A (en) * | 1987-11-13 | 1989-05-16 | Landec Labs, Inc. | Temperature-controlled active agent dispenser |
US4997599A (en) * | 1987-12-08 | 1991-03-05 | Celanese Fibers Inc. | Preparation of water soluble cellulose acetate microspheres |
US5049322A (en) * | 1986-12-31 | 1991-09-17 | Centre National De La Recherche Scientifique (C.N.R.S.) | Process for the preparaton of dispersible colloidal systems of a substance in the form of nanocapsules |
US5120349A (en) * | 1990-12-07 | 1992-06-09 | Landec Labs, Inc. | Microcapsule having temperature-dependent permeability profile |
WO1992019102A1 (en) * | 1991-05-06 | 1992-11-12 | Lim Laboratories, Inc. | Microencapsulated agriculturally active agents and method of producing same |
US5174930A (en) * | 1986-12-31 | 1992-12-29 | Centre National De La Recherche Scientifique (Cnrs) | Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions |
US5192552A (en) * | 1988-12-30 | 1993-03-09 | Egis Gyogyszergyar | Process for preparing microcapsules providing the rapid release of a drug as active ingredient |
US5238686A (en) * | 1986-03-27 | 1993-08-24 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
US5412035A (en) * | 1991-02-12 | 1995-05-02 | Landec Corporation | Pressure-sensitive adhesives |
US5529772A (en) * | 1994-06-09 | 1996-06-25 | Lignotech, Usa, Inc. | Method for producing improved biological pesticides |
US5552149A (en) * | 1993-10-12 | 1996-09-03 | Lignotech Usa, Inc. | Method for microencapsulation of agriculturally active substances |
US5651984A (en) * | 1992-08-04 | 1997-07-29 | Eurand America, Incorporated | Controlled release potassium tablet |
US5665822A (en) * | 1991-10-07 | 1997-09-09 | Landec Corporation | Thermoplastic Elastomers |
US5846554A (en) * | 1993-11-15 | 1998-12-08 | Zeneca Limited | Microcapsules containing suspensions of biologically active compounds and ultraviolet protectant |
EP0901810A2 (en) * | 1997-09-05 | 1999-03-17 | Bayer Ag | Method and apparatus for the continuous mixing of a droplet dispersion in a liquid |
US5981719A (en) * | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6090925A (en) * | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
EP1206928A1 (en) * | 1999-08-24 | 2002-05-22 | Kosé Corporation | Water-containing powder composition, process for producing the same, and cosmetic preparation containing the powder composition |
WO2002083289A2 (en) * | 2001-02-12 | 2002-10-24 | Dober Chemical Corporation | Conrrolled realease cooling additive composition |
US20030122104A1 (en) * | 2001-02-12 | 2003-07-03 | Dober Chemical Corporation | Liquid replacement systems |
US20030143275A1 (en) * | 2001-11-28 | 2003-07-31 | L'oreal | Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
US20040001792A1 (en) * | 2002-06-20 | 2004-01-01 | L'oreal | Cosmetic and/or dermatological use of a composition comprising at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer |
US20050013860A1 (en) * | 2003-07-15 | 2005-01-20 | Gopi Venkatesh | Controlled release potassium chloride tablets |
FR2886845A1 (en) * | 2005-06-13 | 2006-12-15 | Oreal | Anhydrous solid product, useful in cosmetic/pharmaceutical kit for keratinous matters, comprises ascorbic acid or its derivatives and water-soluble or water-dispersible maleic acid copolymer |
US20070148124A1 (en) * | 2004-05-03 | 2007-06-28 | Labib Mohamed E | Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases |
US20080072641A1 (en) * | 2006-08-24 | 2008-03-27 | Arr-Maz Custom Chemicals, Inc. | Dust control of solid granular materials |
US20090178452A1 (en) * | 2006-08-24 | 2009-07-16 | Arr-Maz Custom Chemicals, Inc. | Dust control of solid granular materials |
US20110004150A1 (en) * | 2002-12-31 | 2011-01-06 | Ultra-Sonic Technologies, L.L.C. | Transdermal Delivery Using Encapsulated Agent Activated by Ultrasound and or Heat |
US7883638B2 (en) | 2008-05-27 | 2011-02-08 | Dober Chemical Corporation | Controlled release cooling additive compositions |
WO2018187595A1 (en) * | 2017-04-05 | 2018-10-11 | Andrew Hudson | Additive manufacturing support material |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1148784B (en) * | 1980-04-09 | 1986-12-03 | Eurand Spa | PROCEDURE FOR THE PREPARATION OF MICRO CAPSULES IN A LIQUID VEHICLE |
GB2170104A (en) * | 1985-01-30 | 1986-07-30 | Warner Lambert Co | Coated pharmaceutical dosage forms |
FR2631826B1 (en) * | 1988-05-27 | 1992-06-19 | Centre Nat Rech Scient | PARTICULATE VECTOR USEFUL IN PARTICULAR FOR THE TRANSPORT OF BIOLOGICALLY ACTIVATED MOLECULES AND METHOD FOR THE PREPARATION THEREOF |
FR2646777B1 (en) * | 1989-05-12 | 1993-09-03 | Bio Serae Lab | PROCESS FOR PREPARING AN ANTIMICROBIAL PARTICULATE PRODUCT, ANTIMICROBIAL PRODUCT OBTAINED AND APPLICATIONS |
US9364422B2 (en) | 2013-12-19 | 2016-06-14 | Avon Products, Inc | Styrene maleic anhydride polymers in cosmetics and personal care products |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2333283A (en) * | 1940-12-11 | 1943-11-02 | Wilson Wilbert Moody | Administration capsule |
US2585903A (en) * | 1950-06-16 | 1952-02-19 | Fellows Medical Mfg Company In | Gelatin capsules containing chloral hydrate |
US2770571A (en) * | 1953-08-17 | 1956-11-13 | American Cyanamid Co | Soft gelatin capsule provided with internal barrier |
US2800457A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2800458A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2844512A (en) * | 1954-11-05 | 1958-07-22 | Upjohn Co | Fumagillin enveloped in fatty or waxy substance and enclosed in ultraviolet opaque container |
US2897121A (en) * | 1957-06-04 | 1959-07-28 | Upjohn Co | Pharmaceutical composition |
US2897122A (en) * | 1956-10-04 | 1959-07-28 | Frosst & Co Charles E | Enteric coated product |
US2969331A (en) * | 1958-06-04 | 1961-01-24 | Ncr Co | Process of making dual-walled oil containing capsules |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE561484A (en) * | 1956-06-19 |
-
1958
- 1958-12-22 US US781917A patent/US3242051A/en not_active Expired - Lifetime
-
1959
- 1959-10-28 GB GB36637/59A patent/GB931150A/en not_active Expired
- 1959-12-19 CH CH8206459A patent/CH396847A/en unknown
- 1959-12-22 DE DEU6765A patent/DE1185155B/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2333283A (en) * | 1940-12-11 | 1943-11-02 | Wilson Wilbert Moody | Administration capsule |
US2585903A (en) * | 1950-06-16 | 1952-02-19 | Fellows Medical Mfg Company In | Gelatin capsules containing chloral hydrate |
US2800457A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2800458A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2770571A (en) * | 1953-08-17 | 1956-11-13 | American Cyanamid Co | Soft gelatin capsule provided with internal barrier |
US2844512A (en) * | 1954-11-05 | 1958-07-22 | Upjohn Co | Fumagillin enveloped in fatty or waxy substance and enclosed in ultraviolet opaque container |
US2897122A (en) * | 1956-10-04 | 1959-07-28 | Frosst & Co Charles E | Enteric coated product |
US2897121A (en) * | 1957-06-04 | 1959-07-28 | Upjohn Co | Pharmaceutical composition |
US2969331A (en) * | 1958-06-04 | 1961-01-24 | Ncr Co | Process of making dual-walled oil containing capsules |
Cited By (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3405071A (en) * | 1963-12-30 | 1968-10-08 | Ibm | Process of making microcapsules |
US3336155A (en) * | 1964-01-15 | 1967-08-15 | Ncr Co | Process of coating particles with a polymer |
US3404093A (en) * | 1965-03-29 | 1968-10-01 | Magnaflux Corp | Fluorescent composition for magnetic particle inspection |
US3483132A (en) * | 1966-06-01 | 1969-12-09 | Gen Electric | Bubble dissolution control by film formation |
US3539377A (en) * | 1968-05-07 | 1970-11-10 | Us Army | Method for coating oxidizer particles with a polymer |
US3878121A (en) * | 1971-12-28 | 1975-04-15 | Poudres & Explosifs Ste Nale | Method of encapsulation by coacervation, and the substances obtained |
US3875074A (en) * | 1972-03-06 | 1975-04-01 | Champion Int Corp | Formation of microcapsules by interfacial cross-linking of emulsifier, and microcapsules produced thereby |
US3951851A (en) * | 1972-05-29 | 1976-04-20 | Fuji Photo Film Co., Ltd. | Process of producing aspirin-containing capsules |
US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
US4107071A (en) * | 1977-02-16 | 1978-08-15 | Capsulated Systems, Inc. | Method of producing microcapsules and resulting product |
US4110511A (en) * | 1977-05-25 | 1978-08-29 | The Mead Corporation | Process for the production of a pressure-sensitive carbonless copy sheet using microcapsules formed in situ in a radiation curable binder |
US4230495A (en) * | 1979-02-26 | 1980-10-28 | The Mead Corporation | Process for producing a pressure-sensitive carbonless copy sheet using microcapsules formed in situ in a radiation curable binder |
USRE32079E (en) * | 1979-06-28 | 1986-02-04 | State Of Oregon, By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Method and starter compositions for the growth of acid producing bacteria and bacterial compositions produced thereby |
US4282255A (en) * | 1979-06-28 | 1981-08-04 | State Of Oregon, By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Method and starter compositions for the growth of acid producing bacteria and bacterial compositions produced thereby |
US4389331A (en) * | 1979-10-31 | 1983-06-21 | Tanabe Seiyaku Co., Ltd. | Process for preparing pharmaceutically active compound-containing microcapsules |
US4353962A (en) * | 1980-05-15 | 1982-10-12 | Environmental Chemicals, Inc. | In-flight encapsulation of particles |
US4435383A (en) | 1980-09-05 | 1984-03-06 | E. I. Du Pont De Nemours And Company | Slow release pesticide formulations |
AU583467B2 (en) * | 1981-05-18 | 1989-05-04 | Environmental Chemicals Inc. | In-flight encapsulation of particles |
US4557929A (en) * | 1981-07-22 | 1985-12-10 | E. I. Du Pont De Nemours And Company | Slow release pesticide formulations |
US4637905A (en) * | 1982-03-04 | 1987-01-20 | Batelle Development Corporation | Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones |
US4532123A (en) * | 1982-03-04 | 1985-07-30 | Battelle Development Corporation | Dual Microcapsules and process for their preparation |
WO1985000105A1 (en) * | 1983-06-22 | 1985-01-17 | Ohio State University Research Foundation | Small particle formation and encapsulation |
US4608278A (en) * | 1983-06-22 | 1986-08-26 | The Ohio State University Research Foundation | Small particule formation and encapsulation |
GB2152466A (en) * | 1983-06-22 | 1985-08-07 | Univ Ohio State Res Found | Small particle formation and encapsulation |
US4606940A (en) * | 1984-12-21 | 1986-08-19 | The Ohio State University Research Foundation | Small particle formation and encapsulation |
US5238686A (en) * | 1986-03-27 | 1993-08-24 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
US5049322A (en) * | 1986-12-31 | 1991-09-17 | Centre National De La Recherche Scientifique (C.N.R.S.) | Process for the preparaton of dispersible colloidal systems of a substance in the form of nanocapsules |
US5174930A (en) * | 1986-12-31 | 1992-12-29 | Centre National De La Recherche Scientifique (Cnrs) | Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions |
US4808230A (en) * | 1987-06-16 | 1989-02-28 | Ciba-Geigy Corporation | Organic pigments coated with metal oxides fixed with ethyl cellulose |
EP0296106A3 (en) * | 1987-06-16 | 1991-03-20 | Ciba-Geigy Ag | Organic pigments coated with metal oxides fixed by ethyl cellulose |
EP0296106A2 (en) * | 1987-06-16 | 1988-12-21 | Ciba-Geigy Ag | Organic pigments coated with metal oxides fixed by ethyl cellulose |
WO1989004648A1 (en) * | 1987-11-13 | 1989-06-01 | Landec Labs, Inc. | Temperature-controlled active agent dispenser |
EP0317180A1 (en) * | 1987-11-13 | 1989-05-24 | Landec Labs. Inc. | Temperature-controlled active agent dispenser |
US4830855A (en) * | 1987-11-13 | 1989-05-16 | Landec Labs, Inc. | Temperature-controlled active agent dispenser |
US4997599A (en) * | 1987-12-08 | 1991-03-05 | Celanese Fibers Inc. | Preparation of water soluble cellulose acetate microspheres |
US5192552A (en) * | 1988-12-30 | 1993-03-09 | Egis Gyogyszergyar | Process for preparing microcapsules providing the rapid release of a drug as active ingredient |
US5120349A (en) * | 1990-12-07 | 1992-06-09 | Landec Labs, Inc. | Microcapsule having temperature-dependent permeability profile |
US5783302A (en) * | 1990-12-07 | 1998-07-21 | Landec Corporation | Thermoplastic elastomers |
US5412035A (en) * | 1991-02-12 | 1995-05-02 | Landec Corporation | Pressure-sensitive adhesives |
WO1992019102A1 (en) * | 1991-05-06 | 1992-11-12 | Lim Laboratories, Inc. | Microencapsulated agriculturally active agents and method of producing same |
US5665822A (en) * | 1991-10-07 | 1997-09-09 | Landec Corporation | Thermoplastic Elastomers |
US5651984A (en) * | 1992-08-04 | 1997-07-29 | Eurand America, Incorporated | Controlled release potassium tablet |
US5981719A (en) * | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6090925A (en) * | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US6268053B1 (en) | 1993-03-09 | 2001-07-31 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5552149A (en) * | 1993-10-12 | 1996-09-03 | Lignotech Usa, Inc. | Method for microencapsulation of agriculturally active substances |
US6149843A (en) * | 1993-11-15 | 2000-11-21 | Zeneca Limited | Microcapsules containing suspensions of biologically active compounds and ultraviolet protectant |
US5846554A (en) * | 1993-11-15 | 1998-12-08 | Zeneca Limited | Microcapsules containing suspensions of biologically active compounds and ultraviolet protectant |
US6077522A (en) * | 1993-11-15 | 2000-06-20 | Zeneca Limited | Microcapsules containing suspensions of biologically active compounds and ultraviolet protectant |
US5529772A (en) * | 1994-06-09 | 1996-06-25 | Lignotech, Usa, Inc. | Method for producing improved biological pesticides |
EP0901810A2 (en) * | 1997-09-05 | 1999-03-17 | Bayer Ag | Method and apparatus for the continuous mixing of a droplet dispersion in a liquid |
US6170761B1 (en) | 1997-09-05 | 2001-01-09 | Bayer Aktiengesselschaft | Method and device for the continuous mixing of a droplet dispersion with a liquid |
EP0901810A3 (en) * | 1997-09-05 | 2001-02-07 | Bayer Ag | Method and apparatus for the continuous mixing of a droplet dispersion in a liquid |
US6102309A (en) * | 1997-09-05 | 2000-08-15 | Bayer Aktiengesselschaft | Method and device for the continuous mixing of a droplet dispersion with a liquid |
EP1206928A1 (en) * | 1999-08-24 | 2002-05-22 | Kosé Corporation | Water-containing powder composition, process for producing the same, and cosmetic preparation containing the powder composition |
EP1206928A4 (en) * | 1999-08-24 | 2004-06-02 | Kose Corp | Water-containing powder composition, process for producing the same, and cosmetic preparation containing the powder composition |
KR100718604B1 (en) | 1999-08-24 | 2007-05-16 | 가부시키 가이샤 고세 | A water-containing powder composition, a method for producing the same, and a cosmetic containing the powder composition |
US7524434B2 (en) | 2001-02-12 | 2009-04-28 | Dober Chemical Corporation | Controlled release cooling additive composition |
AU2002320545B2 (en) * | 2001-02-12 | 2007-01-25 | Dober Chemical Corporation | Controlled Release Cooling Additive Composition |
CN1501836B (en) * | 2001-02-12 | 2012-10-10 | 多伯化学公司 | Controlled release cooling additive composition |
US20030122104A1 (en) * | 2001-02-12 | 2003-07-03 | Dober Chemical Corporation | Liquid replacement systems |
WO2002083289A2 (en) * | 2001-02-12 | 2002-10-24 | Dober Chemical Corporation | Conrrolled realease cooling additive composition |
WO2002083289A3 (en) * | 2001-02-12 | 2002-12-19 | Dober Chemical Corp | Conrrolled realease cooling additive composition |
US20050023505A1 (en) * | 2001-02-12 | 2005-02-03 | Dober Chemical Corporation | Controlled release cooling additive composition |
US6878309B2 (en) * | 2001-02-12 | 2005-04-12 | Dober Chemical Corp. | Controlled release cooling additive composition |
US20030143275A1 (en) * | 2001-11-28 | 2003-07-31 | L'oreal | Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
US7560493B2 (en) | 2001-11-28 | 2009-07-14 | L'oreal | Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
US7803354B2 (en) | 2002-06-20 | 2010-09-28 | L'oreal | Cosmetic and/or dermatological use of a composition comprising at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer |
US20040052739A1 (en) * | 2002-06-20 | 2004-03-18 | L'oreal | Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer |
US20040001792A1 (en) * | 2002-06-20 | 2004-01-01 | L'oreal | Cosmetic and/or dermatological use of a composition comprising at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer |
US20040047824A1 (en) * | 2002-06-20 | 2004-03-11 | L'oreal, Paris, France | Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
US7691903B2 (en) | 2002-06-20 | 2010-04-06 | L'oreal | Oxidation-sensitive hydrophilic active principle containing composition and use thereof |
US20040175342A1 (en) * | 2002-06-20 | 2004-09-09 | L'oreal | Process of making and using composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer |
US8691268B2 (en) | 2002-12-31 | 2014-04-08 | Ultra-Sonic Technologies, L.L.C. | Transdermal delivery using encapsulated agent released by ultrasound and/or heat |
US20110004150A1 (en) * | 2002-12-31 | 2011-01-06 | Ultra-Sonic Technologies, L.L.C. | Transdermal Delivery Using Encapsulated Agent Activated by Ultrasound and or Heat |
US20080279937A2 (en) * | 2003-07-15 | 2008-11-13 | Eurand, Inc. | Controlled release potassium chloride tablets |
US7632521B2 (en) | 2003-07-15 | 2009-12-15 | Eurand, Inc. | Controlled release potassium chloride tablets |
US20050013860A1 (en) * | 2003-07-15 | 2005-01-20 | Gopi Venkatesh | Controlled release potassium chloride tablets |
US20070148124A1 (en) * | 2004-05-03 | 2007-06-28 | Labib Mohamed E | Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases |
FR2886845A1 (en) * | 2005-06-13 | 2006-12-15 | Oreal | Anhydrous solid product, useful in cosmetic/pharmaceutical kit for keratinous matters, comprises ascorbic acid or its derivatives and water-soluble or water-dispersible maleic acid copolymer |
US20090178452A1 (en) * | 2006-08-24 | 2009-07-16 | Arr-Maz Custom Chemicals, Inc. | Dust control of solid granular materials |
US20080072641A1 (en) * | 2006-08-24 | 2008-03-27 | Arr-Maz Custom Chemicals, Inc. | Dust control of solid granular materials |
WO2009023652A1 (en) * | 2007-08-15 | 2009-02-19 | Arr-Maz Custom Chemicals, Inc. | Dust control of solid granular materials |
US7883638B2 (en) | 2008-05-27 | 2011-02-08 | Dober Chemical Corporation | Controlled release cooling additive compositions |
WO2018187595A1 (en) * | 2017-04-05 | 2018-10-11 | Andrew Hudson | Additive manufacturing support material |
US11692070B2 (en) | 2017-04-05 | 2023-07-04 | Carnegie Mellon University | Additive manufacturing support material |
US12215202B2 (en) | 2017-04-05 | 2025-02-04 | Carnegie Mellon University | Additive manufacturing support material |
Also Published As
Publication number | Publication date |
---|---|
CH396847A (en) | 1965-08-15 |
DE1185155B (en) | 1965-01-14 |
GB931150A (en) | 1963-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3242051A (en) | Coating by phase separation | |
US3265629A (en) | Coating by phase separation | |
JP3509105B2 (en) | Process for the preparation of microcapsules coated with an active substance with a polymer and in particular novel microcapsules obtained by this method | |
US3539465A (en) | Encapsulation of hydrophilic liquid-in-oil emulsions | |
JP3261707B2 (en) | Pellet manufacturing method | |
US5071706A (en) | Oily, free-flowing, microcapsules | |
Sinha et al. | Chitosan microspheres as a potential carrier for drugs | |
US4656027A (en) | Pharmaceutical mixture | |
US3565559A (en) | Process for making microcapsules | |
US5043161A (en) | Small, oily, free-flowing, silky-smooth, talc-like, dry microcapsules and aqueous formulations containing them | |
US5558880A (en) | Pharmaceutical and other dosage forms | |
US6096344A (en) | Bioerodible porous compositions | |
DE112005000730B4 (en) | Ion-binding polymers and their use | |
CA2302585C (en) | Controlled release formulations | |
US3960757A (en) | Process for encapsulation of medicaments | |
AU2008337269B2 (en) | Formulations comprising exine shells | |
US3851051A (en) | Soft gelatin capsule containing high water content fill | |
CA2169376C (en) | Procedure for encapsulating nsaids | |
Nair et al. | Application of chitosan microspheres as drug carriers: a review | |
EP0076515B1 (en) | Rapidly releasable microcapsules and method for the preparation thereof | |
EP0585688A2 (en) | Aqueous dispersions of zein and controlled release coatings derived therefrom | |
Phaechamud et al. | Chitosan citrate as film former: compatibility with water-soluble anionic dyes and drug dissolution from coated tablet | |
JPS6111933B2 (en) | ||
DE112006002618T5 (en) | Methods and compositions for selectively removing potassium ions from the mammalian gastrointestinal tract | |
GB2170104A (en) | Coated pharmaceutical dosage forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EURAND AMERICA, INCORPORATED, 1464-A, MIAMISBURG-C Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:APPLETON PAPERS INC.;REEL/FRAME:003961/0292 Effective date: 19811130 |